<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title>Frontiers in Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnins.2024.1385189</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Effects of hyperbaric oxygen therapy on autistic behaviors and <italic>GRIN2B</italic> gene expression in valproic acid-exposed rats</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Mohtaj Khorassani</surname> <given-names>Yalda</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2682498/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Moghimi</surname> <given-names>Ali</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2651335/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Khakzad</surname> <given-names>Mohammad Reza</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Fereidoni</surname> <given-names>Masoud</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/949474/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Hassani</surname> <given-names>Delaram</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2682505/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Torbati Gah</surname> <given-names>Javad</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2682456/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Rayan Research Center for Neuroscience &#x0026; Behavior, Department of Biology, Faculty of Science, Ferdowsi University of Mashhad</institution>, <addr-line>Mashhad</addr-line>, <country>Iran</country></aff>
<aff id="aff2"><sup>2</sup><institution>Innovative Medical Research Center and Department of Immunology, Mashhad Medical Branch, Islamic Azad University</institution>, <addr-line>Mashhad</addr-line>, <country>Iran</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Cellular and Molecular Biology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University</institution>, <addr-line>Tehran</addr-line>, <country>Iran</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Biology, Faculty of Science, Mashhad Islamic Azad University</institution>, <addr-line>Mashhad</addr-line>, <country>Iran</country></aff>
<author-notes>
<fn id="fn0001" fn-type="edited-by"><p>Edited by: Suleyman Kaplan, Ondokuz May&#x0131;s University, T&#x00FC;rkiye</p></fn>
<fn id="fn0002" fn-type="edited-by"><p>Reviewed by: Selma Cirrik, Ordu University, T&#x00FC;rkiye</p>
<p>Omur Gulsum Deniz, Abant Izzet Baysal University, T&#x00FC;rkiye</p></fn>
<corresp id="c001">&#x002A;Correspondence: Ali Moghimi, <email>moghimi@um.ac.ir</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>18</volume>
<elocation-id>1385189</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Mohtaj Khorassani, Moghimi, Khakzad, Fereidoni, Hassani and Torbati Gah.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Mohtaj Khorassani, Moghimi, Khakzad, Fereidoni, Hassani and Torbati Gah</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Autism is a complex neurodevelopmental condition characterized by deficits in social interaction, communication, and restricted repetitive behaviors. Hyperbaric oxygen therapy (HBOT) has emerged as a potential treatment for autism, although its effects on behavior and gene expression are not well understood. The <italic>GRIN2B</italic> gene, known for its involvement in encoding a glutamate receptor subunit crucial for neuron communication and associated with autism, was a focus of this study.</p>
</sec>
<sec>
<title>Methods</title>
<p>Using a rat model induced by prenatal exposure to valproic acid, we examined the impact of HBOT on autism-like behaviors and <italic>GRIN2B</italic> gene expression. Male Wistar rats were categorized into four groups: control, VPA (valproic acid-exposed), VPA+HBOT [2 atmosphere absolute (ATA)], and VPA+HBOT (2.5 ATA). The rats underwent several behavioral tests to assess social behavior, anxiety, stereotype and exploratory behaviors, and learning. Following the behavioral tests, the HBOT groups received 15 sessions of HBOT at pressures of 2 and 2.5 (ATA), and their behaviors were re-evaluated. Subsequently, real-time PCR was employed to measure <italic>GRIN2B</italic> gene expression in the frontal lobe.</p>
</sec>
<sec>
<title>Results</title>
<p>Our results indicated that HBOT significantly increased social interaction and exploratory behaviors in VPA-exposed rats, alongside elevated <italic>GRIN2B</italic> gene expression in their frontal lobe.</p>
</sec>
<sec>
<title>Discussion</title>
<p>Our findings imply that HBOT might have a potential role in ameliorating autism-related behaviors in the VPA rat model of autism through potential modulation of <italic>GRIN2B</italic> gene expression. However, additional research is essential to fully comprehend the underlying mechanisms and refine the HBOT protocol for optimizing its effectiveness in improving autism-related symptoms.</p>
</sec>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>hyperbaric oxygen therapy</kwd>
<kwd><italic>GRIN2B</italic> gene</kwd>
<kwd>valproic acid</kwd>
<kwd>social interaction</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="89"/>
<page-count count="13"/>
<word-count count="9566"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Neurodevelopment</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<title>Introduction</title>
<p>Autism is a neurodevelopmental condition in which the development of the brain is affected and it&#x2019;s characterized by difficulties with social communication and interaction as well as restricted and repetitive interests and behaviors (<xref ref-type="bibr" rid="ref1">American Psychiatric Association, 2013</xref>). While memory difficulty is not a diagnostic criterion for autism, studies indicate learning and memory impairments in individuals with autism (<xref ref-type="bibr" rid="ref24">Goh and Peterson, 2012</xref>; <xref ref-type="bibr" rid="ref85">Wang et al., 2017</xref>). According to the World Health Organization, approximately 1 in 100 children worldwide is diagnosed with autism (<xref ref-type="bibr" rid="ref2">Autism, 2023</xref>). Autism manifests on a spectrum, varying in symptom severity, associated traits, and accompanying conditions. As a result, there is no one-size-fits-all approach to autism therapies (<xref ref-type="bibr" rid="ref48">Malik-Soni et al., 2021</xref>).</p>
<p>Glutamate is a major excitatory neurotransmitter and has a key role in neural plasticity as well as cognitive processes including memory and learning (<xref ref-type="bibr" rid="ref88">Yoo et al., 2012</xref>). Altered glutamatergic pathways are associated with autism (<xref ref-type="bibr" rid="ref56">Nisar et al., 2022</xref>), potentially contributing to behavioral and cognitive deficits observed in the spectrum.</p>
<p>Evidence suggests autism affects both metabotropic and ionotropic glutamate receptors, implicating glutamate receptor dysregulation in autism&#x2019;s manifestation (<xref ref-type="bibr" rid="ref11">Choudhury et al., 2012</xref>). N-methyl-d-aspartate (NMDA) receptors (NMDAR) are one of the several glutamate receptor subtypes that may disclose more physiological mechanisms and even offer promising probable therapeutic options for autism. NMDA receptors are neurotransmitter-gated ion channels and NMDAR-mediated signaling has a role in proper development, plasticity, learning, memory, and high cognitive functions (<xref ref-type="bibr" rid="ref9">Burnashev and Szepetowski, 2015</xref>). A study on valproic acid (VPA)-exposed mouse showed that activation of NMDAR regulated sociability (<xref ref-type="bibr" rid="ref8">Burket et al., 2015</xref>).</p>
<p>It is well known that many of the physiological and pharmacological characteristics of NMDA receptors are influenced by the identification of their specific subunits (<xref ref-type="bibr" rid="ref16">Cull-Candy and Leszkiewicz, 2004</xref>). NMDARs are heterotetrametric structures usually composed of two GluN1 subunits and two GluN2 subunits, comprising four subtypes (GluN2A-D) (<xref ref-type="bibr" rid="ref15">Cull-Candy et al., 2001</xref>). Mutations in NMDAR subunits and changes in gene expression are implicated in various neurodevelopmental disorders, including autism (<xref ref-type="bibr" rid="ref65">Rinaldi et al., 2007</xref>; <xref ref-type="bibr" rid="ref88">Yoo et al., 2012</xref>; <xref ref-type="bibr" rid="ref9">Burnashev and Szepetowski, 2015</xref>). The <italic>GRIN2B</italic> gene has been shown to have an important role in behavior. A study showed that the variations present in the <italic>GRIN2B</italic> gene have been associated with the decision-making process (<xref ref-type="bibr" rid="ref55">Ness et al., 2011</xref>). Also, it has been demonstrated that <italic>GRIN2B</italic> plays a critical role in working memory (<xref ref-type="bibr" rid="ref60">Pergola et al., 2016</xref>). Variations in the <italic>GRIN2B</italic> gene correlate with obsessive-compulsive disorder and its symptom dimensions (<xref ref-type="bibr" rid="ref41">Kohlrausch et al., 2016</xref>). Genetic findings suggest <italic>GRIN2B</italic> involvement in schizophrenia and bipolar disorder pathophysiology (<xref ref-type="bibr" rid="ref51">Martucci et al., 2006</xref>).</p>
<p>The frontal cortex, linked to higher cognitive functions and emotional regulation, significantly influences autism-related behaviors (<xref ref-type="bibr" rid="ref14">Collins and Koechlin, 2012</xref>; <xref ref-type="bibr" rid="ref37">Jones and Graff-Radford, 2021</xref>; <xref ref-type="bibr" rid="ref23">Friedman and Robbins, 2022</xref>; <xref ref-type="bibr" rid="ref53">Mohapatra and Wagner, 2023</xref>). Altered frontal cortex activity and connectivity have been implicated in social interaction deficits, repetitive behaviors, and cognitive impairments observed in individuals with Autism (<xref ref-type="bibr" rid="ref33">Hou et al., 2018</xref>; <xref ref-type="bibr" rid="ref49">Margari et al., 2018</xref>; <xref ref-type="bibr" rid="ref89">Zhu et al., 2022</xref>). Therefore, investigating the relationship between glutamatergic signaling, NMDA receptors, and the prefrontal cortex is important for understanding the neurobiology of autism.</p>
<p>There are anecdotal reports of individuals with autism experiencing symptom improvements through Hyperbaric Oxygen Therapy (HBOT) (<xref ref-type="bibr" rid="ref69">Rossignol et al., 2007</xref>, <xref ref-type="bibr" rid="ref68">2012</xref>; <xref ref-type="bibr" rid="ref13">Chungpaibulpatana et al., 2008</xref>; <xref ref-type="bibr" rid="ref67">Rossigno et al., 2009</xref>; <xref ref-type="bibr" rid="ref30">Hao et al., 2020</xref>). Exploring these reports could guide further investigations. Exploring the reported anecdotal benefits of HBOT in individuals with autism offers an avenue for further investigation, potentially paving the way for a non-invasive treatment option if proven effective through rigorous clinical trials.</p>
<p>HBOT involves inhaling nearly 100% oxygen at pressures exceeding sea level pressure (1 ATA) within a hyperbaric chamber [<xref ref-type="bibr" rid="ref82">Undersea and Hyperbaric Medical Society (UHMS), 2019</xref>]. So far, HBOT has shown promise in enhancing cognitive function, spatial learning, and memory post-brain injury (<xref ref-type="bibr" rid="ref31">Harch et al., 2007</xref>; <xref ref-type="bibr" rid="ref45">Liu et al., 2013</xref>), and exhibits neuroprotective effects (<xref ref-type="bibr" rid="ref87">Yang et al., 2023</xref>).</p>
<p>Nevertheless, the effects of HBOT on autism are contradictory, and controlled clinical trials are limited (<xref ref-type="bibr" rid="ref27">Granpeesheh et al., 2010</xref>; <xref ref-type="bibr" rid="ref36">Jepson et al., 2011</xref>; <xref ref-type="bibr" rid="ref72">Sampanthavivat et al., 2012</xref>). Thus, the present study aimed to investigate the effect of HBOT at pressures of 2 and 2.5 atmosphere absolute on autistic-like behaviors and <italic>GRIN2B</italic> gene expression in the VPA-induced rat model of autism.</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<title>Materials and methods</title>
<sec id="sec3">
<title>Animals and groups</title>
<p>Male and female Wistar rats, nearly three months old and weighing approximately 200&#x2013;250 grams, were housed in plastic cages. A total of 11 female and 11 male rats were utilized for the experimental procedures. Each female rat was involved in a single pregnancy only, and none were subjected to a second pregnancy during the study. All animals were kept in standard laboratory conditions at a temperature of 22&#x2009;&#x00B1;&#x2009;2 degrees Celsius, with around 50% humidity, and a 12-h light/dark cycle. Access to food and water was provided <italic>ad libitum</italic>. Mating cages were set up for male and female rats. The appearance of vaginal plugs was considered as the zero-day of pregnancy (<xref ref-type="bibr" rid="ref26">Goyeneche et al., 2003</xref>). Pregnant rats received a single intraperitoneal injection of 500&#x2009;mg/kg VPA (Sajaddaru Co., Iran) dissolved in 3.3&#x2009;mL/kg saline on embryonic day 12.5, except for the control group which did not receive any injections (<xref ref-type="bibr" rid="ref19">Favre et al., 2013</xref>). Pups were weaned on postnatal day 21 and they were examined for morphological malformation (<xref ref-type="bibr" rid="ref71">Saft et al., 2014</xref>). Subsequent experiments were conducted on the male offspring. The pups were categorized into four groups:</p>
<p>(1) The intact control group consisted of wildtype rats (no interventions were administered), (2) Sham, VPA-exposed rats, received prenatal VPA but did not undergo any oxygen treatment, (3) HBOT-2 group comprised VPA-exposed rats that received hyperbaric oxygen therapy at 2 ATA and (4) the HBOT-2.5 comprised VPA-exposed rats that received hyperbaric oxygen therapy at 2.5 ATA.</p>
</sec>
<sec id="sec4">
<title>Ethical consideration</title>
<p>All Experiments were carried out in accordance with the international ethical codes and complied with local institutional regulations at Ferdowsi University of Mashhad (Iran National Committee for Ethics in Biomedical Research). The project obtained ethical approval from the local FUM Ethical Review Committee (IR.UM.REC.1399.117). The study&#x2019;s reporting follows the ARRIVE guidelines.</p>
</sec>
<sec id="sec5">
<title>Behavioral evaluation</title>
<p>Four days after separation from their mother, the pups underwent the three-chamber social interaction test, Y-maze, elevated plus maze, and Morris Water Maze (MWM) tests. These evaluations assessed social behaviors, repetitive behaviors, anxiety, and spatial memory, respectively.</p>
<p>All behavioral assessments were conducted on 25-day-old rats, between 9&#x2009;am and 4&#x2009;pm. One hour before testing, all animal-containing cages were transferred to the laboratory to allow the animals to habituate to the testing room (<xref ref-type="bibr" rid="ref29">H&#x00E5;nell and Marklund, 2014</xref>).</p>
</sec>
<sec id="sec6">
<title>Social interaction test</title>
<p>This test assesses two key aspects of social behavior: &#x201C;Sociability,&#x201D; which is defined as the propensity to spend time with another rat rather than with a nonliving object, and &#x201C;Social Novelty&#x201D; which is the preference for spending time with an unfamiliar rat over a familiar one (<xref ref-type="bibr" rid="ref54">Moy et al., 2004</xref>). The apparatus used was a box (100&#x2009;&#x00D7;&#x2009;40&#x2009;&#x00D7;&#x2009;40&#x2009;cm) divided by separating walls, allowing free access to each chamber. The side chambers contained two identical wire cages. The test comprised four 10-min stages separated by 5-min intervals. To prevent residual odors from influencing the test, all three chambers and cages were cleaned with 75% ethanol both initially and before each stage. In the first stage (habituation), animals were allowed to freely explore the empty chambers and cages. In the second stage called pre-test, two identical nonliving objects were placed in the cages. The third stage was the Social Stimulus Stage: One wire cage contained an unfamiliar rat (social stimulus), while the opposite cage contained an unfamiliar inanimate object (non-social stimulus). In the last stage (Social Novelty Stage), the non-social object was replaced with a novel unfamiliar rat as the novel social stimulus and the social stimulus were at the same place. During these stages, interactions such as following, touching, grooming, and sniffing any body part were recorded using a video camera. The duration of interaction with each stimulus was manually measured. Animals used as stimuli were randomly chosen, matching the test rats in age, sex, and strain (<xref ref-type="bibr" rid="ref64">Rein et al., 2020</xref>).</p>
</sec>
<sec id="sec7">
<title>Elevated plus maze</title>
<p>This test aimed to measure anxiety-like behavior in rats. Rats were placed for 5&#x2009;min in an apparatus consisting of two open arms and two closed arms (each arm 50&#x2009;&#x00D7;&#x2009;10&#x2009;cm and the height 50&#x2009;cm). Animals were positioned in the middle of the maze and time spent in each arm was recorded with a video camera connected to a computer using ANY-maze software. The maze was cleaned with 75% ethanol and allowed to dry after each test to eliminate the odors of previously tested <italic>rats</italic>. The total distance traveled and time spent in each arm was recorded (<xref ref-type="bibr" rid="ref50">Markram et al., 2008</xref>; <xref ref-type="bibr" rid="ref29">H&#x00E5;nell and Marklund, 2014</xref>).</p>
</sec>
<sec id="sec8">
<title>Y-maze</title>
<p>The Y-maze can be used to measure short-term memory, exploratory, and stereotyped patterns of behavior (<xref ref-type="bibr" rid="ref57">Onaolapo, 2012</xref>; <xref ref-type="bibr" rid="ref86">W&#x00F6;hr et al., 2015</xref>). Hence, spontaneous alternation was determined using a Y-maze. The maze, consisting of three equal arms (40&#x2009;&#x00D7;&#x2009;5&#x2009;&#x00D7;&#x2009;30&#x2009;cm) separated by 120-degree angles, resembles the shape of a Y. Rats were placed individually in the start arm and allowed to explore freely for 5&#x2009;min (<xref ref-type="bibr" rid="ref57">Onaolapo, 2012</xref>). The arms were labeled A, B, and C. A video camera connected to a computer running ANY-maze software tracked and recorded the sequence of arm entries and the total distance traveled. An alternation was defined as entry into all three arms consecutively. The percentage of alternation was computed using the formula: [(number of <italic>alternations</italic>) / (total arm entries &#x2212;2)]&#x2009;&#x00D7;&#x2009;100. After each trial, the apparatus was cleaned with 75% ethanol and allowed to dry to remove any residual odors from previous rat trials (<xref ref-type="bibr" rid="ref57">Onaolapo, 2012</xref>; <xref ref-type="bibr" rid="ref29">H&#x00E5;nell and Marklund, 2014</xref>; <xref ref-type="bibr" rid="ref38">Jung et al., 2020</xref>).</p>
</sec>
<sec id="sec9">
<title>Morris water maze (MWM)</title>
<p>The MWM assesses spatial learning and memory capabilities (<xref ref-type="bibr" rid="ref84">Vorhees and Williams, 2006</xref>). The apparatus consisted of a circular black pool, 150&#x2009;cm in diameter and 50&#x2009;cm deep, filled halfway with water maintained at approximately 25&#x2009;&#x00B1;&#x2009;1&#x00B0;C. A platform, matching the pool&#x2019;s color and measuring 9&#x2009;cm in diameter and 25&#x2009;cm in height, was submerged 1&#x2009;cm below the water&#x2019;s surface, making it nearly invisible during training sessions. On the first day, the platform was positioned 1&#x2009;cm above the water&#x2019;s surface and marked with a red flag for visibility by the animals. The pool was enclosed with curtains to minimize distractions for the animals. Inside the pool, above the water&#x2019;s surface, four high-contrast spatial cues were placed. The pool was divided into four quadrants by two axes, with directional markers (North, South, East, and West) at the ends of each line. Rats underwent 5&#x2009;days of spatial training, with each session comprising five 60-s trials and 60-s inter-trial intervals. At the start of each trial, the rat began facing the pool&#x2019;s wall at one of four positions. If the rat located the platform within 60&#x2009;s, it remained on the platform for 5&#x2009;s. However, if the rat did not find the platform, it was gently placed on the platform for 20&#x2009;s. The escape latency and total distance traveled were automatically recorded using the ANY-maze video tracking software (<xref ref-type="bibr" rid="ref84">Vorhees and Williams, 2006</xref>; <xref ref-type="bibr" rid="ref50">Markram et al., 2008</xref>; <xref ref-type="bibr" rid="ref6">Bromley-Brits et al., 2011</xref>).</p>
</sec>
<sec id="sec10">
<title>Hyperbaric oxygen treatment (HBOT)</title>
<p>HBOT was administered to 35-day-old rats using a hyperbaric chamber (Irsa Sakht Asia Co., IR). For this purpose, rats were placed in the hyperbaric chamber. After sealing the chamber, the pressure inside the chamber was gradually increased over a 5-min period until it reached the designated pressure levels. One group was pressurized to 2 ATA, while the second group underwent pressurization to 2.5 ATA. Once the chamber pressure attained the desired levels, the rats remained exposed to this pressure condition for 50&#x2009;min. Throughout this time, a 100% oxygen environment was maintained. The oxygen flow rate was 6 liters per minute. Following the 50-min exposure, the chamber pressure was gradually reduced over a 5-min period to return to atmospheric conditions, totaling the rats&#x2019; exposure duration within the chamber to 60&#x2009;min. After each HBOT session, the rats were returned to their cages. These sessions were conducted once daily for 14 consecutive days (<xref ref-type="bibr" rid="ref78">Simsek et al., 2012</xref>; <xref ref-type="bibr" rid="ref42">K&#x00F6;rp&#x0131;nar and Uzun, 2019</xref>).</p>
<p>All administrations were conducted between 9&#x2009;AM and 11&#x2009;AM to minimize potential effects.</p>
<p>Post-HBOT behavioral tests:</p>
<p>All behavioral tests were repeated after the completion of the HBOT sessions.</p>
</sec>
<sec id="sec11">
<title>Tissue preparation</title>
<p>For tissue sampling, CO2 was used for euthanizing the animals. After opening the skulls, the whole brain was extracted, and the frontal lobe was immediately excised. The excised frontal lobe samples were placed in microtubes containing RNA later solution (Sinaclon Co., Iran) and stored at &#x2212;80&#x00B0;C until molecular examinations commenced.</p>
</sec>
<sec id="sec12">
<title>Real-time PCR</title>
<p>RNA extraction and cDNA synthesis were performed using RNX Plus (Sinnaclon Co, Iran) for total cellular RNA extraction from frontal lobe samples, following the manufacturer&#x2019;s instructions. Primer sequences for the target gene and <italic>GAPDH</italic> gene (used as a reference gene) were designed and determined (shown in <xref ref-type="table" rid="tab1">Table 1</xref>). The RNA was reverse transcribed into single-stranded cDNA using a cDNA synthesis kit (Pars tous Co, Iran) in accordance with the manufacturer&#x2019;s protocol.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption><p>Forward and reverse sequences of the <italic>GRIN2B</italic> and <italic>GAPDH</italic> gene.</p></caption>
<table frame="hsides" rules="groups">
<tbody>
<tr>
<td align="left" valign="top" rowspan="2"><italic>GRIN2B</italic></td>
<td align="left" valign="top">Forward</td>
<td align="left" valign="top">CCCTGGCTACCAGGACTTTG</td>
</tr>
<tr>
<td align="left" valign="top">Reverse</td>
<td align="left" valign="top">GATGGGGCTTTGGAGCTTCT</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2"><italic>GAPDH</italic></td>
<td align="left" valign="top">Forward</td>
<td align="left" valign="top">CAGCAACTCCCACTCTTCCAC</td>
</tr>
<tr>
<td align="left" valign="top">Reverse</td>
<td align="left" valign="top">GTGGTCCAGGGTTTCTTACTC</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The real-time PCR procedure was conducted utilizing a Corbett real-time PCR apparatus. The cDNA samples were amplified employing SYBR-Green in a 20&#x2009;&#x03BC;L reaction mixture comprising 10&#x2009;&#x03BC;L of 2X TaqMan Universal PCR Master Mix, 1&#x2009;&#x03BC;L of 20X TaqMan Gene Expression Assay, and 9&#x2009;&#x03BC;L of cDNA template. The amplification process involved an initial denaturation step at 95&#x00B0;C for 10&#x2009;min, followed by 40&#x2009;cycles of denaturation at 95&#x00B0;C for 15&#x2009;s, and annealing and extension at 60&#x00B0;C for 1&#x2009;min. Subsequently, the real-time PCR data were analyzed using the comparative Ct method to ascertain the relative expression levels of the target genes, which were then normalized to the expression of the reference gene (<xref ref-type="bibr" rid="ref75">Schmittgen and Livak, 2008</xref>). To confirm the specificity of the PCR products, a melting curve analysis was performed. Additionally, non-template controls were included in each run to identify any potential contamination or background signal.</p>
</sec>
<sec id="sec13">
<title>Statistical analysis</title>
<p>The Behavioral tests and Real-time PCR results underwent analysis in R software (<xref ref-type="bibr" rid="ref62">R Core Team, 2022</xref>). Initially, the data for each test were evaluated for normal distribution using the Shapiro&#x2013;Wilk test. Subsequently, for the three-chamber social interaction test, exploratory behavior, and spontaneous alternation in the Y-maze test, the Welch <italic>t</italic>-test was used to compare the control group to each treatment group. For the elevated plus maze data, the non-parametric Mann&#x2013;Whitney test was employed. Then, the paired <italic>t</italic>-test was applied to assess the pre-and post-treatment data for comparison. The MWM data underwent analysis using a repeated measure analysis of variance (ANOVA), adjusted with the Bonferroni correction, followed by Tukey&#x2019;s <italic>post hoc</italic> test. Gene expression data were analyzed using one-way ANOVA, and Tukey&#x2019;s <italic>post hoc</italic> test was conducted to determine the specific differences among groups. The repeated measure ANOVA was performed using the nlme package (<xref ref-type="bibr" rid="ref61">Pinheiro and Bates, 2000</xref>), while <italic>post hoc</italic> tests were conducted using functions from the multcomp package (<xref ref-type="bibr" rid="ref32">Hothorn et al., 2008</xref>). A significance level of <italic>p</italic>-value &#x2264;0.05 was considered. The statistics reported in the text and figures represent the mean&#x2009;&#x00B1;&#x2009;SEM.</p>
</sec>
</sec>
<sec sec-type="results" id="sec14">
<title>Results</title>
<sec id="sec15">
<title>Tail malformation</title>
<p>Out of the 36 rats exposed to VPA <italic>in utero</italic>, 28 exhibited tail malformations, indicating that 80% of the VPA-exposed rats showed abnormalities in their tails. Apart from tail malformations, no other body malformations were observed (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption><p>Tail malformation in rats exposed to <italic>in utero</italic> VPA. <bold>(A)</bold> One bent in the tail. <bold>(B,C)</bold> Two bents in the tail. <bold>(D)</bold> Four bents in the tail.</p></caption>
<graphic xlink:href="fnins-18-1385189-g001.tif"/>
</fig>
<p>The observed tail malformations were classified into two groups: (1) Rats that exhibited a single bend along their tail, and (2) Rats that displayed multiple bends along their tail, often having two bends, with one case showing four bends (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p>
</sec>
<sec id="sec16">
<title>Behavioral tests</title>
<sec id="sec17">
<title>Three-chamber social interaction test</title>
<sec id="sec18">
<title>Social preference</title>
<p>Prior to treatment, HBOT-2 rats spent relatively less time with the social stimulus compared to the control group, although this difference was not statistically significant (<italic>t</italic>&#x2009;=&#x2009;1.6247, df&#x2009;=&#x2009;12.687, <italic>p</italic>-value&#x2009;=&#x2009;0.1288). However, significant differences were observed when comparing the control group with HBOT-2.5 (<italic>t</italic>&#x2009;=&#x2009;2.2817, df&#x2009;=&#x2009;12.771, <italic>p</italic>-value&#x2009;=&#x2009;0.04032) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption><p>The effects of HBOT on social behavior using the Three-chamber Social Interaction test. <bold>(A)</bold> Duration of interaction with the social stimulus: VPA-exposed rats displayed reduced interaction time, and HBOT notably increased this behavior. <bold>(B)</bold> Interaction time with the non-social stimulus: VPA-exposed rats exhibited more interest in communicating with the non-social stimulus, with varying effects observed post-hyperbaric oxygen therapy across groups. <bold>(C)</bold> Percentage of time spent with the unfamiliar social stimulus: VPA-exposed rats showed decreased interaction time with the unfamiliar stimulus, which was enhanced following HBOT (&#x002A;<italic>p</italic>-value&#x2009;&#x2264;&#x2009;0.05, &#x002A;&#x002A;<italic>p</italic>-value <italic>&#x2264;</italic> 0.01, &#x002A;&#x002A;&#x002A;<italic>p</italic>-value <italic>&#x2264;&#x2009;0.001</italic>, &#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic>-value&#x2009;&#x2264;&#x2009;0.0001). <italic>n</italic>(Control)&#x2009;=&#x2009;9, <italic>n</italic>(HBOT-2)&#x2009;=&#x2009;11, <italic>n</italic>(HBOT-2.5)&#x2009;=&#x2009;12.</p></caption>
<graphic xlink:href="fnins-18-1385189-g002.tif"/>
</fig>
<p>In comparison to VPA-exposed rats, control animals spent significantly less time with the non-social stimulus. This difference was statistically significant between the control and VPA-exposed rats of the HBOT groups [control and HBOT-2 (<italic>t</italic>&#x2009;=&#x2009;&#x2212;2.5722, df&#x2009;=&#x2009;8.3353, <italic>p</italic>-value&#x2009;=&#x2009;0.03194), control and HBOT-2.5 (<italic>t</italic>&#x2009;=&#x2009;&#x2212;1.4812, df&#x2009;=&#x2009;14.668, <italic>p</italic>-value&#x2009;=&#x2009;0.1597)] (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p>
<p>Post-treatment, there was no significant difference observed in the duration of interaction with the social stimulus within the HBOT-2 group (<italic>t</italic>&#x2009;=&#x2009;&#x2212;0.28618, df&#x2009;=&#x2009;9, <italic>p</italic>-value&#x2009;=&#x2009;0.7812). Conversely, the HBOT-2.5 group exhibited a significant increase in time spent with the social stimulus post-treatment (<italic>t</italic>&#x2009;=&#x2009;&#x2212;3.8013, df&#x2009;=&#x2009;10, <italic>p</italic>-value&#x2009;=&#x2009;0.003478) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>).</p>
<p>Comparison of the time spent with social stimulus between the control group with the post-treatment data of both HBOT-2 (<italic>t</italic>&#x2009;=&#x2009;0.59695, df&#x2009;=&#x2009;17.983, <italic>p</italic>-value&#x2009;=&#x2009;0.558) and HBOT-2.5 (<italic>t</italic>&#x2009;=&#x2009;&#x2212;0.32648, df&#x2009;=&#x2009;10.545, <italic>p</italic>-value&#x2009;=&#x2009;0.7505) groups did not yield a significant difference (<xref ref-type="fig" rid="fig2">Figure 2A</xref>).</p>
<p>After receiving HBOT sessions, HBOT-2 rats spent less time with the non-social stimulus (<italic>t</italic>&#x2009;=&#x2009;0.77831, df&#x2009;=&#x2009;8, <italic>p</italic>-value&#x2009;=&#x2009;0.4588). Conversely, HBOT-2.5 rats exhibited a significant increase in interaction duration with the non-social stimulus post-treatment (<italic>t</italic>&#x2009;=&#x2009;&#x2212;4.2893, df&#x2009;=&#x2009;10, <italic>p</italic>-value&#x2009;=&#x2009;0.001588) (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p>
<p>Comparatively, VPA-exposed rats interacted significantly more with the non-social stimulus after treatment in comparison to control rats [control and HBOT-2 (<italic>t</italic>&#x2009;=&#x2009;&#x2212;3.9507, df&#x2009;=&#x2009;12.784, <italic>p</italic>-value&#x2009;=&#x2009;0.001711), control and HBOT-2.5 (<italic>t</italic>&#x2009;=&#x2009;&#x2212;5.7189, df&#x2009;=&#x2009;12.62, <italic>p</italic>-value&#x2009;=&#x2009;7.925e-05)] (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p>
</sec>
</sec>
</sec>
<sec id="sec19">
<title>Social novelty</title>
<p>In the novelty preference test, the percentage of s interaction&#x2019;animal with the unfamiliar social stimulus has been measured by calculating the interaction time with the unfamiliar stimulus compared to the total interaction time (time interacted with unfamiliar social stimulus/(time interacted with unfamiliar social stimulus + time interacted with familiar social stimulus) &#x00D7; 100).</p>
<p>Before treatment, VPA-exposed rats exhibited impaired preference in interacting with the unfamiliar social stimulus compared to the control group [HBOT-2 and control (<italic>t</italic>&#x2009;=&#x2009;2.5196, df&#x2009;=&#x2009;11.854, <italic>p</italic>-value&#x2009;=&#x2009;0.02714) and HBOT-2.5 and control (<italic>t</italic>&#x2009;=&#x2009;1.3114, df&#x2009;=&#x2009;16.765, <italic>p</italic>-value&#x2009;=&#x2009;0.2074)] (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</p>
<p>Following HBOT administration, interaction with the unfamiliar social stimulus increased in both groups, with statistical significance observed only in HBOT-2 [HBOT-2 before and after (<italic>t</italic>&#x2009;=&#x2009;&#x2212;4.4773, df&#x2009;=&#x2009;9, <italic>p</italic>-value&#x2009;=&#x2009;0.001538)], while not in HBOT-2.5 [HBOT-2.5 before and after (<italic>t</italic>&#x2009;=&#x2009;&#x2212;2.0733, df&#x2009;=&#x2009;10, <italic>p</italic>-value&#x2009;=&#x2009;0.06492)] (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</p>
<p>Comparison of post-treatment data with the control group did not reveal a significant difference [HBOT-2 and control (<italic>t</italic>&#x2009;=&#x2009;&#x2212;0.58468, df&#x2009;=&#x2009;10.445, <italic>p</italic>-value&#x2009;=&#x2009;0.5712), HBOT-2.5 and control (<italic>t</italic>&#x2009;=&#x2009;&#x2212;0.058536, df&#x2009;=&#x2009;10.545, <italic>p</italic>-value&#x2009;=&#x2009;0.9544)] (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</p>
</sec>
<sec id="sec20">
<title>Elevated plus maze</title>
<p>In this test, the percentage of time spent in the open arms relative to the total test time was calculated to measure anxiety (time spent in the open arms/total test time &#x00D7; 100). Similarly, using the same equation, the percentage of distance traveled in the open arms was also computed.</p>
<p>Compared to control rats, VPA-exposed rats exhibited increased time spent in the open arms. This difference was statistically significant in HBOT-2.5 (<italic>t</italic>&#x2009;=&#x2009;&#x2212;2.3226, df&#x2009;=&#x2009;14.61, <italic>p</italic>-value&#x2009;=&#x2009;0.03509), while not significant in HBOT-2 (<italic>t</italic>&#x2009;=&#x2009;&#x2212;1.5596, df&#x2009;=&#x2009;14.427, <italic>p</italic>-value&#x2009;=&#x2009;0.1405) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>).</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption><p>The effects of HBOT on elevated plus maze. <bold>(A)</bold> Percentage of time spent in the open arms: VPA-exposed rats spent more time in the open arms compared to the control group. Following HBOT sessions, both groups showed reduced time spent in the open arms. <bold>(B)</bold> Percentage of total distance traveled in the open arms: VPA-exposed rats traveled a greater distance in the open arms, but this distance decreased after HBOT sessions. (&#x002A;<italic>p</italic>-value <italic>&#x2264;</italic> 0.05, &#x002A;&#x002A;<italic>p</italic>-value&#x2009;&#x2264;&#x2009;0.01). <italic>n</italic>(Control)&#x2009;=&#x2009;9, <italic>n</italic>(HBOT-2)&#x2009;=&#x2009;11, <italic>n</italic>(HBOT-2.5)&#x2009;=&#x2009;12.</p></caption>
<graphic xlink:href="fnins-18-1385189-g003.tif"/>
</fig>
<p>Post HBOT administration, both groups displayed a decrease in the percentage of time spent in the open arms. This reduction was statistically significant in HBOT-2.5 (<italic>t</italic>&#x2009;=&#x2009;3.7104, df&#x2009;=&#x2009;11, <italic>p</italic>-value&#x2009;=&#x2009;0.003439), but not in HBOT-2 (<italic>t</italic>&#x2009;=&#x2009;1.7032, df&#x2009;=&#x2009;10, <italic>p</italic>-value&#x2009;=&#x2009;0.1194) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>).</p>
<p>Comparing control rats with HBOT-2 rats after treatment did not reveal a significant difference (<italic>t</italic>&#x2009;=&#x2009;0.47785, df&#x2009;=&#x2009;17.177, <italic>p</italic>-value&#x2009;=&#x2009;0.6388). However, a significant difference was observed between control rats and HBOT-2.5 rats after HBOT sessions (<italic>t</italic>&#x2009;=&#x2009;2.7111, df&#x2009;=&#x2009;9.7132, <italic>p</italic>-value&#x2009;=&#x2009;0.02243) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>).</p>
<p>While VPA-exposed rats showed increased distance traveled in the open arms compared to the control group, this difference was not statistically significant [control and HBOT-2 (<italic>W</italic>&#x2009;=&#x2009;42.5, <italic>p</italic>-value&#x2009;=&#x2009;0.6213), control and HBOT-2.5 (<italic>W</italic>&#x2009;=&#x2009;37, <italic>p</italic>-value&#x2009;=&#x2009;0.2469)]. Post HBOT sessions, there was a decrease in the percentage of distance traveled in the open arms, notably significant in the HBOT-2.5 group [HBOT-2.5 before and after (V&#x2009;=&#x2009;75, <italic>p</italic>-value&#x2009;=&#x2009;0.002441), HBOT-2 before and after (V&#x2009;=&#x2009;47, <italic>p</italic>-value&#x2009;=&#x2009;0.2402)]. Furthermore, a significant difference was observed between HBOT-2.5 after receiving HBOT and the control group [HBOT-2.5 and control (<italic>W</italic>&#x2009;=&#x2009;91.5, <italic>p</italic>-value&#x2009;=&#x2009;0.006846), HBOT-2 and control (<italic>W</italic>&#x2009;=&#x2009;59.5, <italic>p</italic>-value&#x2009;=&#x2009;0.4703)] (<xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p>
</sec>
<sec id="sec21">
<title>Y-maze</title>
<sec id="sec22">
<title>Exploratory behavior</title>
<p>Exploratory behavior was assessed based on the distance traveled by the animals. The data indicated that VPA-exposed animals traveled a significantly shorter distance during the test [HBOT-2 and control (<italic>t</italic>&#x2009;=&#x2009;2.5095, df&#x2009;=&#x2009;14.887, <italic>p</italic>-value&#x2009;=&#x2009;0.02415), HBOT-2.5 and control (<italic>t</italic>&#x2009;=&#x2009;2.2142, df&#x2009;=&#x2009;17.951, <italic>p</italic>-value&#x2009;=&#x2009;0.04)] (<xref ref-type="fig" rid="fig4">Figure 4A</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption><p>The effects of HBOT on exploratory and spontaneous behavior in Y-maze. <bold>(A)</bold> Average distance traveled by rats: VPA-exposed rats traveled less than the control rats. HBOT at 2 ATA increased exploratory behavior, while 2.5 ATA showed no significant impact. <bold>(B)</bold> Percentage of spontaneous alternation behavior: No significant differences in repetitive behavior were observed between the control and VPA-exposed rats. However, the HBOT-2 group showed a significant increase in SAB percentage, indicating reduced repetitive behavior post-hyperbaric oxygen therapy. (&#x002A;<italic>p</italic>-value&#x2009;&#x2264;&#x2009;0.05, &#x002A;&#x002A;<italic>p-</italic>value&#x2009;&#x2264;&#x2009;0.01, &#x002A;&#x002A;&#x002A;<italic>p-</italic>value&#x2009;&#x2264;&#x2009;0.001). <italic>n</italic>(Control)&#x2009;=&#x2009;9, <italic>n</italic>(HBOT-2)&#x2009;=&#x2009;11, <italic>n</italic>(HBOT-2.5)&#x2009;=&#x2009;12.</p></caption>
<graphic xlink:href="fnins-18-1385189-g004.tif"/>
</fig>
<p>Post-treatment with hyperbaric oxygen, HBOT-2 rats significantly increased their travel distance compared to before treatment (<italic>t</italic>&#x2009;=&#x2009;&#x2212;2.4803, df&#x2009;=&#x2009;10, <italic>p</italic>-value&#x2009;=&#x2009;0.03253), while HBOT-2.5 rats exhibited a decrease, although not significant (<italic>t</italic>&#x2009;=&#x2009;0.6981, df&#x2009;=&#x2009;11, <italic>p</italic>-value&#x2009;=&#x2009;0.4996) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>).</p>
<p>After HBO administration, no significant difference was observed between HBOT-2 and the control group (<italic>t</italic>&#x2009;=&#x2009;&#x2212;0.48742, df&#x2009;=&#x2009;16.573, <italic>p</italic>-value&#x2009;=&#x2009;0.6323). However, a statistically significant difference was found between HBOT-2.5 and the control (<italic>t</italic>&#x2009;=&#x2009;3.4413, df&#x2009;=&#x2009;14.449, <italic>p</italic>-value&#x2009;=&#x2009;0.003814) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>).</p>
</sec>
<sec id="sec23">
<title>Spontaneous alternation behavior</title>
<p>Spontaneous alternation behavior (SAB) assessed repetitive behavior. As shown in <xref ref-type="fig" rid="fig4">Figure 4B</xref>, no statistically significant differences were observed in the percentage of SAB between the control rats and VPA-exposed rats before intervention [control and HBOT-2 (<italic>t</italic>&#x2009;=&#x2009;1.8551, df&#x2009;=&#x2009;16.982, <italic>p</italic>-value&#x2009;=&#x2009;0.08102), control and HBOT-2.5 (<italic>t</italic>&#x2009;=&#x2009;1.1041, df&#x2009;=&#x2009;17.667, <italic>p</italic>-value&#x2009;=&#x2009;0.2844)].</p>
<p>Comparing pre-and post-treatment data indicated a significant increase in SAB in HBOT-2 rats after receiving HBOT (<italic>t</italic>&#x2009;=&#x2009;&#x2212;2.4169, df&#x2009;=&#x2009;10, <italic>p</italic>-value&#x2009;=&#x2009;0.03625). Although there was a slight increase in HBOT-2.5 rats, it was not significant (<italic>t</italic>&#x2009;=&#x2009;&#x2212;0.28192, df&#x2009;=&#x2009;11, <italic>p</italic>-value&#x2009;=&#x2009;0.7832) (<xref ref-type="fig" rid="fig4">Figure 4B</xref>).</p>
<p>When comparing control rats with those that received hyperbaric oxygen, no differences were observed [control and HBOT-2 (<italic>t</italic>&#x2009;=&#x2009;&#x2212;0.14608, df&#x2009;=&#x2009;14.238, <italic>p</italic>-value&#x2009;=&#x2009;0.8859), control and HBOT-2.5 (<italic>t</italic>&#x2009;=&#x2009;1.0794, df&#x2009;=&#x2009;10.998, <italic>p</italic>-value&#x2009;=&#x2009;0.3035)] (<xref ref-type="fig" rid="fig4">Figure 4B</xref>).</p>
</sec>
</sec>
<sec id="sec24">
<title>Morris water maze</title>
<p>The maze was used to assess any impairments in learning and memory. Results from the repeated measure ANOVA indicated significant differences between groups (<italic>p</italic>-value &#x003C;0.0001). As shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>, the learning process was observed in the sham rats, yet no statistical differences were found between the control and the sham animals throughout all five days of training (<italic>p</italic>-value&#x2009;=&#x2009;0.491).</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption><p>The effects of HBOT on learning using Morris Water Maze. <bold>(A)</bold> Escape latency to reach the platform within 5&#x2009;days of the test: There was no significant difference in escape latency between the control and sham rats. However, both HBOT-receiving groups showed significantly lower escape latency compared to the control and sham groups. <bold>(B&#x2013;E)</bold> Track plot of the swimming path. <italic>n</italic>(Control)&#x2009;=&#x2009;9, <italic>n</italic>(sham)&#x2009;=&#x2009;12, <italic>n</italic>(HBOT-2)&#x2009;=&#x2009;11, <italic>n</italic>(HBOT-2.5)&#x2009;=&#x2009;12.</p></caption>
<graphic xlink:href="fnins-18-1385189-g005.tif"/>
</fig>
<p>Post-treatment analysis revealed a noteworthy decrease in the time taken by HBOT-2 rats to find the platform after receiving hyperbaric oxygen therapy, compared to the sham and control groups that did not receive HBOT (Sham and HBOT-2: <italic>p</italic>-value &#x003C;2e-16, Sham and HBOT-2.5: <italic>p</italic>-value &#x003C;2e-16, Control and HBOT-2: <italic>p</italic>-value&#x2009;=&#x2009;1.75e-11, Control and HBOT-2.5: <italic>p</italic>-value&#x2009;=&#x2009;1.24e-11) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>).</p>
<p>However, no statistical difference was found between HBOT-2 and HBOT-2.5 (<italic>p</italic>-value&#x2009;=&#x2009;1.000) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>).</p>
</sec>
<sec id="sec25">
<title>Real-time PCR</title>
<p>Gene expression analysis was conducted in 58-day-old rats. The gene fold data revealed significant differences between groups (<italic>p</italic>-value&#x2009;=&#x2009;1.82e-12). Tukey&#x2019;s <italic>post hoc</italic> analysis illustrated that the expression of the <italic>GRIN2B</italic> gene was markedly higher in control rats compared to the sham rats (<italic>p</italic>-value ~0) (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption><p>The effects of HBOT on the <italic>GRIN2B</italic> expression. The sham group exhibited significantly lower gene expression compared to the control group (<italic>p</italic>-value ~0). However, both HBOT-receiving groups displayed a notable increase in gene expression in comparison to the sham group (HBOT-2 <italic>p</italic>-value&#x2009;=&#x2009;0.0062312, HBOT-2.5 <italic>p</italic>-value&#x2009;=&#x2009;0.0088335). Despite this increase, gene expression in the HBOT-2 and HBOT-2.5 groups remained significantly lower than in the control group (<italic>p</italic>-value~0 for both) (&#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic>-value&#x2009;&#x2264;&#x2009;0.0001, &#x002A;&#x002A;&#x002A;<italic>p</italic>-value&#x2009;&#x2264;&#x2009;0.001). <italic>n</italic>(Control)&#x2009;=&#x2009;9, <italic>n</italic>(sham)&#x2009;=&#x2009;12, <italic>n</italic>(HBOT-2)&#x2009;=&#x2009;11, <italic>n</italic>(HBOT-2.5)&#x2009;=&#x2009;12.</p></caption>
<graphic xlink:href="fnins-18-1385189-g006.tif"/>
</fig>
<p>It has been demonstrated in <xref ref-type="fig" rid="fig6">Figure 6</xref> that the <italic>GRIN2B</italic> gene expression has significantly increased in rats after undergoing HBOT [sham and HBOT-2 (<italic>p</italic>-value&#x2009;=&#x2009;0.0062312), sham and HBOT-2.5 (<italic>p</italic>-value&#x2009;=&#x2009;0.0088335)].</p>
<p>Despite this observed increase in gene expression post-treatment, the <italic>GRIN2B</italic> expression in both HBOT groups remained notably lower than in the control group [control and HBOT-2 (<italic>p</italic>-value ~0), control and HBOT-2.5 (<italic>p</italic>-value ~0)] (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p>
<p>Furthermore, following the administration of hyperbaric oxygen, there was no significant difference in gene expression between the HBOT-2 and HBOT-2.5 groups (<italic>p</italic>-value&#x2009;=&#x2009;0.9970551) (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="sec26">
<title>Discussion</title>
<p>Hyperbaric oxygen therapy shows promise as a potential approach for addressing cognitive disorders, as suggested by emerging research. The first aim of the present study was to investigate the effect of HBOT on several autism-related behaviors and then to measure if this treatment has effects at the gene level in animal models of autism. For the second purpose, we chose the <italic>GRIN2B</italic> gene that plays a role in Glutamate signaling. Our findings confirm that a single injection of VPA on gestational day 12.5 induced autism-like behavioral patterns in rat offspring.</p>
<sec id="sec27">
<title>Morphological abnormalities</title>
<p>Our initial finding revealed that rats exposed to prenatal VPA exhibited tail malformations in 80% of the rats consistent with previous reports (<xref ref-type="bibr" rid="ref22">Foley et al., 2012</xref>; <xref ref-type="bibr" rid="ref40">Kim et al., 2013</xref>). In contrast, two studies, one utilizing 500&#x2009;mg/kg of VPA and the other 600&#x2009;mg/kg, reported tail malformations in 10 and 34% of rats, respectively (<xref ref-type="bibr" rid="ref19">Favre et al., 2013</xref>; <xref ref-type="bibr" rid="ref71">Saft et al., 2014</xref>). These studies suggest that exposure to valproic acid during critical stages of pregnancy, such as neural tube closure, may trigger teratogenic effects in offspring, however, the exact mechanism requires further investigation. Despite these varying observations, understanding the higher incidence of this anomaly in our rats compared to previous studies requires additional research into genetic and embryonic factors.</p>
</sec>
<sec id="sec28">
<title>Behavioral tests</title>
<sec id="sec29">
<title>Social interactions</title>
<p>Our findings align with prior research (<xref ref-type="bibr" rid="ref3">Bambini-Junior et al., 2011</xref>; <xref ref-type="bibr" rid="ref35">Jaramillo et al., 2014</xref>), indicating that prenatal VPA exposure leads to social deficits in rats. Specifically, VPA-exposed rats tend to spend more time interacting with inanimate objects and familiar individuals, rather than engaging with unfamiliar ones. The results indicated that HBOT at the pressure of 2 and 2.5 ATA generally reduced social reluctance and increased social interaction, consistent with the observations of <xref ref-type="bibr" rid="ref47">Luo et al. (2020)</xref>. In fact, our observations suggest a potential decrease in social anxiety and fear of encountering new individuals in VPA-exposed rats following HBOT.</p>
<p>It&#x2019;s noteworthy that <xref ref-type="bibr" rid="ref79">Spencer et al. (2005)</xref> measured the number of active approaches to the stimulus instead of the interaction duration. According to their theory, after the approach has taken place, the duration of the encounter is dependent on both rats, the one who initiates it and the recipient one. Although we did not measure this criterion, we acknowledge its potential significance as we noticed instances where the tested animal attempted interaction, but the stimulus appeared occupied with its own activities, such as grooming or exploring, and paid minimal attention to the tested animal&#x2019;s presence.</p>
</sec>
<sec id="sec30">
<title>Anxiety</title>
<p>This study assessed anxiety levels in rats using the elevated plus maze (EPM), a behavior often linked to autism. According to our results, VPA-exposed rats spent more time in open arms, indicative of lower anxiety levels compared to the control group. While our findings align with some studies (<xref ref-type="bibr" rid="ref77">Schneider et al., 2005</xref>; <xref ref-type="bibr" rid="ref20">Fereshetyan et al., 2021</xref>), conflicting research suggests that prenatal VPA exposure actually increases anxiety levels (<xref ref-type="bibr" rid="ref35">Jaramillo et al., 2014</xref>; <xref ref-type="bibr" rid="ref63">Rajizadeh et al., 2019</xref>).</p>
<p>Our study&#x2019;s findings suggest a potential increase in anxiety levels in HBOT-treated rats, contrasting with previous studies that have shown promising outcomes in reducing anxiety levels in VPA-exposed rats (<xref ref-type="bibr" rid="ref59">Peng et al., 2010</xref>) or even studies indicating no effect of HBOT on anxiety (<xref ref-type="bibr" rid="ref21">Fischer et al., 2022</xref>). The differences observed in outcomes may be attributed to variations in experimental conditions. Moreover, autistic behaviors vary widely and can appear paradoxical in therapeutic settings due to their complexity and variety. According to a 2022 study (<xref ref-type="bibr" rid="ref21">Fischer et al., 2022</xref>), there&#x2019;s a proposed critical age window for HBOT administration to reduce anxiety-like behavior, which might contribute to our observed differences.</p>
</sec>
<sec id="sec31">
<title>Exploratory and repetitive behavior</title>
<p>In this study, we employed the Y-maze to measure exploratory behavior, that is, the desire to discover new environments compared to familiar environments, as well as to measure repetitive behavior. Our findings revealed that VPA-exposed rats traveled shorter distances within the maze compared to the control group. This observation might suggest either reduced interest in exploring new environments or heightened anxiety in unfamiliar settings. Post-treatment, the group that received HBOT at 2 ATA displayed nearly the same behavior as the control group, exhibiting a substantial increase in distance traveled. However, in the HBOT-2.5 group, there was a slight decrease in distance covered. This contradictory effect between the two pressures might be linked to increased anxiety levels noted earlier in the HBOT-2.5 group, warranting more detailed investigations into underlying mechanisms.</p>
<p>Interestingly, the percentage of spontaneous alternation behavior in VPA-exposed rats did not significantly differ from the control group, suggesting a lack of pronounced repetitive behavior. This outcome contrasts with findings from some studies (<xref ref-type="bibr" rid="ref76">Schneider and Przew&#x0142;ocki, 2004</xref>; <xref ref-type="bibr" rid="ref58">Pels&#x0151;czi et al., 2019</xref>; <xref ref-type="bibr" rid="ref52">McKinnell et al., 2021</xref>) reporting increased repetitive behaviors in similar models. Our findings suggested the potential for HBOT to ameliorate repetitive behavior in VPA-exposed rats; however, as there is a lack of research on HBOT&#x2019;s effects specifically on rat behavior, we lack comparative data for our results.</p>
<p>Overall, the association between prenatal VPA exposure and repetitive behavior in rats is likely to be complex, multifactorial, and likely influenced by a spectrum of individual and pre/post-natal environmental factors. Further research is crucial to unravel the intricacies of this relationship.</p>
</sec>
<sec id="sec32">
<title>Spatial learning and memory</title>
<p>Our study did not reveal any statistical disparities between VPA-exposed rats and the control group in terms of spatial learning and memory, aligning with the findings of certain researchers (<xref ref-type="bibr" rid="ref50">Markram et al., 2008</xref>; <xref ref-type="bibr" rid="ref3">Bambini-Junior et al., 2011</xref>). However, contrasting studies have reported impaired spatial learning and memory in VPA-exposed rats (<xref ref-type="bibr" rid="ref33">Hou et al., 2018</xref>; <xref ref-type="bibr" rid="ref63">Rajizadeh et al., 2019</xref>; <xref ref-type="bibr" rid="ref39">Kim et al., 2022</xref>).</p>
<p>In <xref ref-type="fig" rid="fig5">Figure 5</xref>, it&#x2019;s evident that HBOT significantly reduced the escape latency to locate the platform across the five days of the experiment. Similar observations in other studies (<xref ref-type="bibr" rid="ref45">Liu et al., 2013</xref>; <xref ref-type="bibr" rid="ref25">Gottfried et al., 2021</xref>), support the notion that HBOT holds the potential for enhancing spatial learning abilities in the VPA-exposed rat model of autism.</p>
</sec>
<sec id="sec33">
<title>Molecular studies</title>
<p>Our study revealed significantly reduced expression of the <italic>GRIN2B</italic> gene, responsible for encoding the GluN2B subunit of the NMDA receptor, in VPA-exposed rats compared to the control group. These findings have been consistent across various research, including studies involving autistic patients (<xref ref-type="bibr" rid="ref9">Burnashev and Szepetowski, 2015</xref>; <xref ref-type="bibr" rid="ref34">Hu et al., 2016</xref>; <xref ref-type="bibr" rid="ref4">Bell et al., 2018</xref>). However, contradictory reports exist, showing increased GRIN2B expression in autism (<xref ref-type="bibr" rid="ref65">Rinaldi et al., 2007</xref>; <xref ref-type="bibr" rid="ref12">Chuang et al., 2014</xref>), contrasting our results. We believe that the existing contradiction may be due to the complexity of the autism disorder or down-up regulation mechanisms.</p>
<p>According to the findings of our study, HBOT with absolute pressures of 2 and 2.5 atmosphere significantly increased the expression of the <italic>GRIN2B</italic> gene compared to the VPA-exposed group. Yet, even after HBOT, gene expression levels remained lower than those in the control group. Interestingly, there was no variance in gene expression between the HBOT-2 and HBOT-2.5 groups, suggesting that the increase of 0.5 ATA did not elicit a noticeable impact on gene expression.</p>
<sec id="sec34">
<title>HBOT&#x2019; mechanism of action</title>
<p>HBOT can affect behavior in several ways. First, HBOT can increase cerebral blood flow (<xref ref-type="bibr" rid="ref10">Chen, 2007</xref>). This enhanced oxygen delivery may improve the function of brain cells, including neurons in the PFC, and potentially contribute to improved behaviors. Increased oxygen levels could promote synaptic plasticity and neurotransmission. Also, there are studies that found benefits related to a reduction in cerebral edema, apoptosis, cerebral glucose utilization, vascular density, and synaptic remodeling, each of which has effects on improved functional and cognitive outcomes (<xref ref-type="bibr" rid="ref74">Schimmel et al., 2023</xref>).</p>
<p>The other impact of HBOT is through inflammation and oxidative stress. Hyperoxia generated during HBOT may stimulate the preservation of I&#x03BA;B&#x03B1; and thereby inhibit NF-&#x03BA;B release, resulting in less gene transcription of pro-inflammatory cytokines and, thus, an anti-inflammatory state despite oxidative stress (<xref ref-type="bibr" rid="ref17">De Wolde et al., 2021</xref>). Some studies suggest that autism is associated with inflammation and oxidative stress in the brain (<xref ref-type="bibr" rid="ref66">Rose et al., 2012</xref>; <xref ref-type="bibr" rid="ref44">Liu et al., 2022</xref>; <xref ref-type="bibr" rid="ref83">Usui et al., 2023</xref>). HBOT has anti-inflammatory and antioxidant effects. It may help reduce neuroinflammation and oxidative stress, which can contribute to improved gene expression and behavior.</p>
<p>It has been shown that HBOT increases the rate of angiogenesis (<xref ref-type="bibr" rid="ref80">Tal et al., 2017</xref>; <xref ref-type="bibr" rid="ref7">Buckley and Cooper, 2022</xref>). This can improve perfusion and balance inflammation which leads to improved autism-related behaviors in VPA-exposed rats. In addition, HBOT has been proposed to enhance neuroplasticity (<xref ref-type="bibr" rid="ref5">Boussi-Gross et al., 2013</xref>; <xref ref-type="bibr" rid="ref18">Efrati et al., 2013</xref>). This increased neuroplasticity might play a role in improving social and behavioral deficits in the rat model.</p>
<p>Additionally, HBOT has the capacity to alter gene expression through two primary mechanisms: oxygen-responsive genes and epigenetic modifications. Studies have shown that HBOT can increase the levels of oxygen radicals (<xref ref-type="bibr" rid="ref17">De Wolde et al., 2021</xref>) although reactive compounds containing oxygen are usually harmful to cells when accumulated to relatively high concentrations, they are also instrumental in the control of the activity of a myriad of proteins, and control both the upregulation and downregulation of gene expression (<xref ref-type="bibr" rid="ref28">Hancock, 2021</xref>). ROS species can mediate transcription factors, such as hypoxia-inducible factor (HIF), AP-1, ATF, and NF-kappaB (<xref ref-type="bibr" rid="ref81">Turpaev, 2002</xref>; <xref ref-type="bibr" rid="ref28">Hancock, 2021</xref>). So, changes in oxygen levels can lead to alterations in gene expression.</p>
<p>Epigenetic changes, such as DNA methylation and histone modifications, play a crucial role in regulating gene expression. Some research suggests that HBOT has been associated with changes in DNA methylation patterns and, hence it may potentially lead to changes in gene expression profiles (<xref ref-type="bibr" rid="ref46">Liu et al., 2020</xref>).</p>
<p>Given the crucial function of this gene in the modulation of glutamatergic signaling and in the regulation of synaptic activity, its aberrant activation has been implicated in several neurological disorders, including autism (<xref ref-type="bibr" rid="ref88">Yoo et al., 2012</xref>; <xref ref-type="bibr" rid="ref73">Sceniak et al., 2019</xref>). Based on some research, a decrease in the expression or function of the <italic>GRIN2B</italic> gene can impair NMDA-dependent signaling and can disrupt the excitatory-inhibitory balance of the middle area of the frontal lobe causing some autism-like behaviors such as social interaction disorders (<xref ref-type="bibr" rid="ref70">Rudebeck et al., 2008</xref>; <xref ref-type="bibr" rid="ref88">Yoo et al., 2012</xref>; <xref ref-type="bibr" rid="ref43">Lee et al., 2016</xref>; <xref ref-type="bibr" rid="ref4">Bell et al., 2018</xref>). The increased expression of the <italic>GRIN2B</italic> gene due to HBOT suggests a potential link to the improvement observed in behaviors. This elevation in <italic>GRIN2B</italic> expression might influence NMDA receptor function, which could potentially impact the excitation-inhibition balance in the brain.</p>
</sec>
</sec>
</sec>
</sec>
<sec sec-type="conclusions" id="sec35">
<title>Conclusion</title>
<p>Generally, the group that got HBOT at a pressure of 2 ATA showed greater improvement in social interaction and exploratory behaviors, and the group that received HBOT at a pressure of 2.5 ATA exhibited better improvement in the social novelty test. Molecular studies revealed the downregulation of the <italic>GRIN2B</italic> gene in VPA-exposed rats. HBOT at varying pressures enhanced <italic>GRIN2B</italic> gene expression, suggesting a potential mechanism for behavioral improvement.</p>
<p>Finally, these findings strongly suggest that HBOT holds promise as a potential intervention for addressing the impairments associated with autism. However, further investigation is warranted to thoroughly understand its mechanisms and optimize its application for clinical intervention.</p>
</sec>
<sec sec-type="data-availability" id="sec36">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary materials, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="ethics-statement" id="sec37">
<title>Ethics statement</title>
<p>The animal study was approved by Iran National Committee for Ethics in Biomedical Research. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="sec38">
<title>Author contributions</title>
<p>YM: Investigation, Methodology, Writing &#x2013; original draft. AM: Conceptualization, Resources, Supervision, Writing &#x2013; review &#x0026; editing. MK: Conceptualization, Writing &#x2013; review &#x0026; editing. MF: Methodology, Supervision, Writing &#x2013; review &#x0026; editing. DH: Investigation, Writing &#x2013; original draft. JT: Methodology, Writing &#x2013; review &#x0026; editing.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec39">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article. This research was supported financially by the Ferdowsi University of Mashhad, Iran (grant number: 3/53007) and the Innovative Medical Research Center and Department of Immunology, Mashhad Medical Branch, Islamic Azad University, Iran.</p>
</sec>
<ack>
<p>We acknowledge M. Bagher Erfanian for his assistance in statistical analysis and M. Dashti and R. Alipanah for their help during the behavioral tests.</p>
</ack>
<sec sec-type="COI-statement" id="sec40">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="book"><person-group person-group-type="author"><collab id="coll1">American Psychiatric Association</collab></person-group>. (<year>2013</year>). <source>Diagnostic and statistical manual of mental disorders</source>. <publisher-name>American Psychiatric Publishing</publisher-name>: <publisher-loc>Washington, DC</publisher-loc>.</citation></ref>
<ref id="ref2"><citation citation-type="web"><person-group person-group-type="author"><collab id="coll2">Autism</collab></person-group>. (<year>2023</year>). Autism. Available at: <ext-link xlink:href="https://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders</ext-link></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bambini-Junior</surname> <given-names>V.</given-names></name> <name><surname>Rodrigues</surname> <given-names>L.</given-names></name> <name><surname>Behr</surname> <given-names>G. A.</given-names></name> <name><surname>Moreira</surname> <given-names>J. C. F.</given-names></name> <name><surname>Riesgo</surname> <given-names>R.</given-names></name> <name><surname>Gottfried</surname> <given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters</article-title>. <source>Brain Res.</source> <volume>1408</volume>, <fpage>8</fpage>&#x2013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.brainres.2011.06.015</pub-id>, PMID: <pub-id pub-id-type="pmid">21767826</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname> <given-names>S.</given-names></name> <name><surname>Maussion</surname> <given-names>G.</given-names></name> <name><surname>Jefri</surname> <given-names>M.</given-names></name> <name><surname>Peng</surname> <given-names>H.</given-names></name> <name><surname>Theroux</surname> <given-names>J. F.</given-names></name> <name><surname>Silveira</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Disruption of GRIN2B impairs differentiation in human neurons</article-title>. <source>Stem Cell Rep</source> <volume>11</volume>, <fpage>183</fpage>&#x2013;<lpage>196</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.stemcr.2018.05.018</pub-id>, PMID: <pub-id pub-id-type="pmid">29937144</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boussi-Gross</surname> <given-names>R.</given-names></name> <name><surname>Golan</surname> <given-names>H.</given-names></name> <name><surname>Fishlev</surname> <given-names>G.</given-names></name> <name><surname>Bechor</surname> <given-names>Y.</given-names></name> <name><surname>Volkov</surname> <given-names>O.</given-names></name> <name><surname>Bergan</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury &#x2013; randomized prospective trial</article-title>. <source>PLoS One</source> <volume>8</volume>:<fpage>79995</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0079995</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bromley-Brits</surname> <given-names>K.</given-names></name> <name><surname>Deng</surname> <given-names>Y.</given-names></name> <name><surname>Song</surname> <given-names>W.</given-names></name></person-group> (<year>2011</year>). <article-title>Morris water Maze test for learning and memory deficits in Alzheimer&#x2019;s disease model mice</article-title>. <source>J. Vis. Exp.</source> <volume>53</volume>:<fpage>2920</fpage>. doi: <pub-id pub-id-type="doi">10.3791/2920</pub-id>, PMID: <pub-id pub-id-type="pmid">21808223</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Buckley</surname> <given-names>C. J.</given-names></name> <name><surname>Cooper</surname> <given-names>J. S.</given-names></name></person-group> (<year>2022</year>). <source>Hyperbaric oxygen effects on angiogenesis</source>. <publisher-name>St. Petersburg</publisher-name>: <publisher-loc>FL</publisher-loc>.</citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burket</surname> <given-names>J. A.</given-names></name> <name><surname>Benson</surname> <given-names>A. D.</given-names></name> <name><surname>Tang</surname> <given-names>A. H.</given-names></name> <name><surname>Deutsch</surname> <given-names>S. I.</given-names></name></person-group> (<year>2015</year>). <article-title>NMDA receptor activation regulates sociability by its effect on mTOR signaling activity</article-title>. <source>Prog. Neuro-Psychopharmacol. Biol. Psychiatry</source> <volume>60</volume>, <fpage>60</fpage>&#x2013;<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1016/J.PNPBP.2015.02.009</pub-id>, PMID: <pub-id pub-id-type="pmid">25703582</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burnashev</surname> <given-names>N.</given-names></name> <name><surname>Szepetowski</surname> <given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>NMDA receptor subunit mutations in neurodevelopmental disorders</article-title>. <source>Curr. Opin. Pharmacol.</source> <volume>20</volume>, <fpage>73</fpage>&#x2013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1016/J.COPH.2014.11.008</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>L.</given-names></name></person-group> (<year>2007</year>). <article-title>Hyperbaric oxygen therapy for cerebral blood flow and electroencephalogram in patients with acute cerebral infarctionChoice for therapeutic occasion</article-title>. <source>Neural Regen. Res.</source> <volume>2</volume>, <fpage>171</fpage>&#x2013;<lpage>174</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s1673-5374(07)60038-3</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choudhury</surname> <given-names>P. R.</given-names></name> <name><surname>Lahiri</surname> <given-names>S.</given-names></name> <name><surname>Rajamma</surname> <given-names>U.</given-names></name></person-group> (<year>2012</year>). <article-title>Glutamate mediated signaling in the pathophysiology of autism spectrum disorders</article-title>. <source>Pharmacol. Biochem. Behav.</source> <volume>100</volume>, <fpage>841</fpage>&#x2013;<lpage>849</lpage>. doi: <pub-id pub-id-type="doi">10.1016/J.PBB.2011.06.023</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname> <given-names>H. C.</given-names></name> <name><surname>Huang</surname> <given-names>T. N.</given-names></name> <name><surname>Hsueh</surname> <given-names>Y. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Neuronal excitation upregulates Tbr1, a high-confidence risk gene of autism, mediating Grin2b expression in the adult brain</article-title>. <source>Front. Cell. Neurosci.</source> <volume>8</volume>:<fpage>280</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fncel.2014.00280</pub-id>, PMID: <pub-id pub-id-type="pmid">25309323</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chungpaibulpatana</surname> <given-names>J.</given-names></name> <name><surname>Sumpatanarax</surname> <given-names>T.</given-names></name> <name><surname>Thadakul</surname> <given-names>N.</given-names></name> <name><surname>Chantharatreerat</surname> <given-names>C.</given-names></name> <name><surname>Konkaew</surname> <given-names>M.</given-names></name> <name><surname>Aroonlimsawas</surname> <given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Hyperbaric oxygen therapy in Thai autistic children</article-title>. <source>J. Med. Assoc. Thail.</source> <volume>91</volume>, <fpage>1232</fpage>&#x2013;<lpage>1238</lpage>. PMID: <pub-id pub-id-type="pmid">18788696</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname> <given-names>A.</given-names></name> <name><surname>Koechlin</surname> <given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Reasoning, learning, and creativity: frontal lobe function and human decision-making</article-title>. <source>PLoS Biol.</source> <volume>10</volume>:<fpage>e1001293</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pbio.1001293</pub-id>, PMID: <pub-id pub-id-type="pmid">22479152</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cull-Candy</surname> <given-names>S.</given-names></name> <name><surname>Brickley</surname> <given-names>S.</given-names></name> <name><surname>Farrant</surname> <given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>NMDA receptor subunits: diversity, development and disease</article-title>. <source>Curr. Opin. Neurobiol.</source> <volume>11</volume>, <fpage>327</fpage>&#x2013;<lpage>335</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0959-4388(00)00215-4</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cull-Candy</surname> <given-names>S. G.</given-names></name> <name><surname>Leszkiewicz</surname> <given-names>D. N.</given-names></name></person-group> (<year>2004</year>). <article-title>Role of distinct NMDA receptor subtypes at central synapses. Science&#x2019;s STKE: signal transduction knowledge</article-title>. <source>Environment</source> <volume>2004</volume>:<fpage>re16</fpage>. doi: <pub-id pub-id-type="doi">10.1126/STKE.2552004RE16</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Wolde</surname> <given-names>S. D.</given-names></name> <name><surname>Hulskes</surname> <given-names>R. H.</given-names></name> <name><surname>Weenink</surname> <given-names>R. P.</given-names></name> <name><surname>Hollmann</surname> <given-names>M. W.</given-names></name> <name><surname>Van Hulst</surname> <given-names>R. A.</given-names></name></person-group> (<year>2021</year>). <article-title>The effects of hyperbaric oxygenation on oxidative stress, inflammation and angiogenesis</article-title>. <source>Biomol. Ther.</source> <volume>11</volume>:<fpage>1210</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biom11081210</pub-id>, PMID: <pub-id pub-id-type="pmid">34439876</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Efrati</surname> <given-names>S.</given-names></name> <name><surname>Fishlev</surname> <given-names>G.</given-names></name> <name><surname>Bechor</surname> <given-names>Y.</given-names></name> <name><surname>Volkov</surname> <given-names>O.</given-names></name> <name><surname>Bergan</surname> <given-names>J.</given-names></name> <name><surname>Kliakhandler</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Hyperbaric oxygen induces late neuroplasticity in post stroke patients &#x2013; randomized, prospective trial</article-title>. <source>PLoS One</source> <volume>8</volume>:<fpage>e53716</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0053716</pub-id>, PMID: <pub-id pub-id-type="pmid">23335971</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Favre</surname> <given-names>M. R.</given-names></name> <name><surname>Barkat</surname> <given-names>T. R.</given-names></name> <name><surname>LaMendola</surname> <given-names>D.</given-names></name> <name><surname>Khazen</surname> <given-names>G.</given-names></name> <name><surname>Markram</surname> <given-names>H.</given-names></name> <name><surname>Markram</surname> <given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>General developmental health in the VPA-rat model of autism</article-title>. <source>Front. Behav. Neurosci.</source> <volume>7</volume>:<fpage>88</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnbeh.2013.00088</pub-id>, PMID: <pub-id pub-id-type="pmid">23898245</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fereshetyan</surname> <given-names>K.</given-names></name> <name><surname>Chavushyan</surname> <given-names>V.</given-names></name> <name><surname>Danielyan</surname> <given-names>M.</given-names></name> <name><surname>Yenkoyan</surname> <given-names>K.</given-names></name></person-group> (<year>2021</year>). <article-title>Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder</article-title>. <source>Sci. Rep.</source> <volume>11</volume>:<fpage>23471</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-021-02994-6</pub-id>, PMID: <pub-id pub-id-type="pmid">34873263</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>I.</given-names></name> <name><surname>Shohat</surname> <given-names>S.</given-names></name> <name><surname>Levy</surname> <given-names>G.</given-names></name> <name><surname>Bar</surname> <given-names>E.</given-names></name> <name><surname>Trangle</surname> <given-names>S. S.</given-names></name> <name><surname>Efrati</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Hyperbaric oxygen therapy alleviates social behavior dysfunction and Neuroinflammation in a mouse model for autism Spectrum disorders</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume>:<fpage>1077</fpage>. doi: <pub-id pub-id-type="doi">10.3390/IJMS231911077</pub-id>, PMID: <pub-id pub-id-type="pmid">36232395</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foley</surname> <given-names>A. G.</given-names></name> <name><surname>Gannon</surname> <given-names>S.</given-names></name> <name><surname>Rombach-Mullan</surname> <given-names>N.</given-names></name> <name><surname>Prendergast</surname> <given-names>A.</given-names></name> <name><surname>Barry</surname> <given-names>C.</given-names></name> <name><surname>Cassidy</surname> <given-names>A. W.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Class I histone deacetylase inhibition ameliorates social cognition and cell adhesion molecule plasticity deficits in a rodent model of autism spectrum disorder</article-title>. <source>Neuropharmacology</source> <volume>63</volume>, <fpage>750</fpage>&#x2013;<lpage>760</lpage>. doi: <pub-id pub-id-type="doi">10.1016/J.NEUROPHARM.2012.05.042</pub-id>, PMID: <pub-id pub-id-type="pmid">22683514</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname> <given-names>N. P.</given-names></name> <name><surname>Robbins</surname> <given-names>T. W.</given-names></name></person-group> (<year>2022</year>). <article-title>The role of prefrontal cortex in cognitive control and executive function</article-title>. <source>Neuropsychopharmacology</source> <volume>47</volume>:<fpage>1132</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41386-021-01132-0</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goh</surname> <given-names>S.</given-names></name> <name><surname>Peterson</surname> <given-names>B. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Imaging evidence for disturbances in multiple learning and memory systems in persons with autism spectrum disorders</article-title>. <source>Dev. Med. Child Neurol.</source> <volume>54</volume>, <fpage>208</fpage>&#x2013;<lpage>213</lpage>. doi: <pub-id pub-id-type="doi">10.1111/J.1469-8749.2011.04153.X</pub-id>, PMID: <pub-id pub-id-type="pmid">22269006</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gottfried</surname> <given-names>I.</given-names></name> <name><surname>Schottlender</surname> <given-names>N.</given-names></name> <name><surname>Ashery</surname> <given-names>U.</given-names></name></person-group> (<year>2021</year>). <article-title>Hyperbaric oxygen treatment&#x2014;from mechanisms to cognitive improvement</article-title>. <source>Biomol. Ther.</source> <volume>11</volume>:<fpage>1520</fpage>. doi: <pub-id pub-id-type="doi">10.3390/BIOM11101520</pub-id>, PMID: <pub-id pub-id-type="pmid">34680155</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goyeneche</surname> <given-names>A. A.</given-names></name> <name><surname>Deis</surname> <given-names>R. P.</given-names></name> <name><surname>Gibori</surname> <given-names>G.</given-names></name> <name><surname>Telleria</surname> <given-names>C. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Progesterone promotes survival of the rat corpus luteum in the absence of cognate receptors</article-title>. <source>Biol. Reprod.</source> <volume>68</volume>, <fpage>151</fpage>&#x2013;<lpage>158</lpage>. doi: <pub-id pub-id-type="doi">10.1095/biolreprod.102.007898</pub-id>, PMID: <pub-id pub-id-type="pmid">12493707</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Granpeesheh</surname> <given-names>D.</given-names></name> <name><surname>Tarbox</surname> <given-names>J.</given-names></name> <name><surname>Dixon</surname> <given-names>D. R.</given-names></name> <name><surname>Wilke</surname> <given-names>A. E.</given-names></name> <name><surname>Allen</surname> <given-names>M. S.</given-names></name> <name><surname>Bradstreet</surname> <given-names>J. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Randomized trial of hyperbaric oxygen therapy for children with autism</article-title>. <source>Res. Autism Spectr. Disord.</source> <volume>4</volume>, <fpage>268</fpage>&#x2013;<lpage>275</lpage>. doi: <pub-id pub-id-type="doi">10.1016/J.RASD.2009.09.014</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hancock</surname> <given-names>J. T.</given-names></name></person-group> (<year>2021</year>). <article-title>Oxygen is instrumental for biological signaling: an overview</article-title>. <source>Oxygen</source> <volume>1</volume>, <fpage>3</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.3390/oxygen1010002</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>H&#x00E5;nell</surname> <given-names>A.</given-names></name> <name><surname>Marklund</surname> <given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Structured evaluation of rodent behavioral tests used in drug discovery research</article-title>. <source>Front. Behav. Neurosci.</source> <volume>8</volume>:<fpage>252</fpage>. doi: <pub-id pub-id-type="doi">10.3389/FNBEH.2014.00252/ABSTRACT</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname> <given-names>Y.</given-names></name> <name><surname>Dong</surname> <given-names>X.</given-names></name> <name><surname>Zhang</surname> <given-names>M.</given-names></name> <name><surname>Liu</surname> <given-names>H.</given-names></name> <name><surname>Zhu</surname> <given-names>L.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name></person-group> (<year>2020</year>). <article-title>Effects of hyperbaric oxygen therapy on the expression levels of the inflammatory factors interleukin-12p40, macrophage inflammatory protein-1&#x03B2;, platelet-derived growth factor-BB, and interleukin-1 receptor antagonist in keloids</article-title>. <source>Medicine</source> <volume>99</volume>:<fpage>e19857</fpage>. doi: <pub-id pub-id-type="doi">10.1097/MD.0000000000019857</pub-id>, PMID: <pub-id pub-id-type="pmid">32312010</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harch</surname> <given-names>P. G.</given-names></name> <name><surname>Kriedt</surname> <given-names>C.</given-names></name> <name><surname>Meter</surname> <given-names>K. W.</given-names><prefix>Van</prefix></name> <name><surname>James</surname> <given-names>R.</given-names></name></person-group> (<year>2007</year>). <article-title>Hyperbaric oxygen therapy improves spatial learning and memory in a rat model of chronic traumatic brain injury</article-title>. <source>Brain Res.</source>, <volume>1174</volume>, <fpage>120</fpage>&#x2013;<lpage>129</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.brainres.2007.06.105</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hothorn</surname> <given-names>T.</given-names></name> <name><surname>Bretz</surname> <given-names>F.</given-names></name> <name><surname>Westfall</surname> <given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>Simultaneous inference in general parametric models</article-title>. <source>Biometrical J.</source> <volume>50</volume>, <fpage>346</fpage>&#x2013;<lpage>363</lpage>. doi: <pub-id pub-id-type="doi">10.1002/BIMJ.200810425</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname> <given-names>Q.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>D.</given-names></name> <name><surname>Yang</surname> <given-names>F.</given-names></name> <name><surname>Wang</surname> <given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>A developmental study of abnormal behaviors and altered GABAergic signaling in the VPA-treated rat model of autism</article-title>. <source>Front Behav Neurosci</source> <volume>12</volume>, <fpage>1</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.3389/fnbeh.2018.00182</pub-id>, PMID: <pub-id pub-id-type="pmid">30186123</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>C.</given-names></name> <name><surname>Chen</surname> <given-names>W.</given-names></name> <name><surname>Myers</surname> <given-names>S. J.</given-names></name> <name><surname>Yuan</surname> <given-names>H.</given-names></name> <name><surname>Traynelis</surname> <given-names>S. F.</given-names></name></person-group> (<year>2016</year>). <article-title>Human GRIN2B variants in neurodevelopmental disorders</article-title>. <source>J. Pharmacol. Sci.</source> <volume>132</volume>, <fpage>115</fpage>&#x2013;<lpage>121</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jphs.2016.10.002</pub-id>, PMID: <pub-id pub-id-type="pmid">27818011</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaramillo</surname> <given-names>T. C.</given-names></name> <name><surname>Liu</surname> <given-names>S.</given-names></name> <name><surname>Pettersen</surname> <given-names>A.</given-names></name> <name><surname>Birnbaum</surname> <given-names>S. G.</given-names></name> <name><surname>Powell</surname> <given-names>C. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Autism-related Neuroligin-3 mutation alters social behavior and spatial learning</article-title>. <source>Autism Res.</source> <volume>7</volume>, <fpage>264</fpage>&#x2013;<lpage>272</lpage>. doi: <pub-id pub-id-type="doi">10.1002/aur.1362</pub-id>, PMID: <pub-id pub-id-type="pmid">24619977</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jepson</surname> <given-names>B.</given-names></name> <name><surname>Granpeesheh</surname> <given-names>D.</given-names></name> <name><surname>Tarbox</surname> <given-names>J.</given-names></name> <name><surname>Olive</surname> <given-names>M. L.</given-names></name> <name><surname>Stott</surname> <given-names>C.</given-names></name> <name><surname>Braud</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Controlled evaluation of the effects of hyperbaric oxygen therapy on the behavior of 16 children with autism spectrum disorders</article-title>. <source>J. Autism Dev. Disord.</source> <volume>41</volume>, <fpage>575</fpage>&#x2013;<lpage>588</lpage>. doi: <pub-id pub-id-type="doi">10.1007/S10803-010-1075-Y</pub-id>, PMID: <pub-id pub-id-type="pmid">20680427</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>D. T.</given-names></name> <name><surname>Graff-Radford</surname> <given-names>J.</given-names></name></person-group> (<year>2021</year>). <article-title>Executive dysfunction and the prefrontal cortex</article-title>. <source>Continuum Lifelong Learn. Neurol.</source> <volume>27</volume>, <fpage>1586</fpage>&#x2013;<lpage>1601</lpage>. doi: <pub-id pub-id-type="doi">10.1212/CON.0000000000001009</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname> <given-names>D. H.</given-names></name> <name><surname>Ahn</surname> <given-names>S. M.</given-names></name> <name><surname>Pak</surname> <given-names>M. E.</given-names></name> <name><surname>Lee</surname> <given-names>H. J.</given-names></name> <name><surname>Jung</surname> <given-names>Y. J.</given-names></name> <name><surname>Kim</surname> <given-names>K. B.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Therapeutic effects of anodal transcranial direct current stimulation in a rat model of adhd</article-title>. <source>eLife</source> <volume>9</volume>:<fpage>56359</fpage>. doi: <pub-id pub-id-type="doi">10.7554/ELIFE.56359</pub-id>, PMID: <pub-id pub-id-type="pmid">32955434</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>U. J.</given-names></name> <name><surname>Hong</surname> <given-names>N.</given-names></name> <name><surname>Ahn</surname> <given-names>J. C.</given-names></name></person-group> (<year>2022</year>). <article-title>Photobiomodulation attenuated cognitive dysfunction and Neuroinflammation in a prenatal Valproic acid-induced autism Spectrum disorder mouse model</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume>:<fpage>16099</fpage>. doi: <pub-id pub-id-type="doi">10.3390/IJMS232416099/S1</pub-id>, PMID: <pub-id pub-id-type="pmid">36555737</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>K. C.</given-names></name> <name><surname>Kim</surname> <given-names>P.</given-names></name> <name><surname>Go</surname> <given-names>H. S.</given-names></name> <name><surname>Choi</surname> <given-names>C. S.</given-names></name> <name><surname>Park</surname> <given-names>J. H.</given-names></name> <name><surname>Kim</surname> <given-names>H. J.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder</article-title>. <source>J. Neurochem.</source> <volume>124</volume>, <fpage>832</fpage>&#x2013;<lpage>843</lpage>. doi: <pub-id pub-id-type="doi">10.1111/JNC.12147</pub-id>, PMID: <pub-id pub-id-type="pmid">23311691</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kohlrausch</surname> <given-names>F. B.</given-names></name> <name><surname>Giori</surname> <given-names>I. G.</given-names></name> <name><surname>Melo-Felippe</surname> <given-names>F. B.</given-names></name> <name><surname>Vieira-Fonseca</surname> <given-names>T.</given-names></name> <name><surname>Velarde</surname> <given-names>L. G. C.</given-names></name> <name><surname>de Salles Andrade</surname> <given-names>J. B.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Association of GRIN2B gene polymorphism and obsessive compulsive disorder and symptom dimensions: a pilot study</article-title>. <source>Psychiatry Res.</source> <volume>243</volume>, <fpage>152</fpage>&#x2013;<lpage>155</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.psychres.2016.06.027</pub-id>, PMID: <pub-id pub-id-type="pmid">27394963</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x00F6;rp&#x0131;nar</surname> <given-names>S.</given-names></name> <name><surname>Uzun</surname> <given-names>H.</given-names></name></person-group> (<year>2019</year>). <article-title>The effects of hyperbaric oxygen at different pressures on oxidative stress and antioxidant status in rats</article-title>. <source>Medicina (Lithuania)</source> <volume>55</volume>:<fpage>205</fpage>. doi: <pub-id pub-id-type="doi">10.3390/medicina55050205</pub-id>, PMID: <pub-id pub-id-type="pmid">31137620</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>E.</given-names></name> <name><surname>Rhim</surname> <given-names>I.</given-names></name> <name><surname>Lee</surname> <given-names>J. W.</given-names></name> <name><surname>Ghim</surname> <given-names>J. W.</given-names></name> <name><surname>Lee</surname> <given-names>S.</given-names></name> <name><surname>Kim</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Enhanced neuronal activity in the medial prefrontal cortex during social approach behavior</article-title>. <source>J. Neurosci.</source> <volume>36</volume>, <fpage>6926</fpage>&#x2013;<lpage>6936</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0307-16.2016</pub-id>, PMID: <pub-id pub-id-type="pmid">27358451</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>Lin</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Khan</surname> <given-names>N. U.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Tang</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Oxidative stress in autism Spectrum disorder&#x2014;current Progress of mechanisms and biomarkers</article-title>. <source>Front. Psychiatry</source> <volume>13</volume>:<fpage>813304</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2022.813304</pub-id>, PMID: <pub-id pub-id-type="pmid">35299821</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>S.</given-names></name> <name><surname>Shen</surname> <given-names>G. Y.</given-names></name> <name><surname>Deng</surname> <given-names>S. K.</given-names></name> <name><surname>Wang</surname> <given-names>X. B.</given-names></name> <name><surname>Wu</surname> <given-names>Q. F.</given-names></name> <name><surname>Guo</surname> <given-names>A. S.</given-names></name></person-group> (<year>2013</year>). <article-title>Hyperbaric oxygen therapy improves cognitive functioning after brain injury</article-title>. <source>Neural Regen. Res.</source> <volume>8</volume>, <fpage>3334</fpage>&#x2013;<lpage>3343</lpage>. doi: <pub-id pub-id-type="doi">10.3969/j.issn.1673-5374.2013.35.008</pub-id>, PMID: <pub-id pub-id-type="pmid">25206655</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>K.</given-names></name> <name><surname>Wu</surname> <given-names>H.</given-names></name> <name><surname>Gao</surname> <given-names>R.</given-names></name> <name><surname>Han</surname> <given-names>G.</given-names></name></person-group> (<year>2020</year>). <article-title>DNA methylation may be involved in the analgesic effect of hyperbaric oxygen via regulating FUNDC1</article-title>. <source>Pain Res. Manag.</source> <volume>2020</volume>, <fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2020/1528362</pub-id>, PMID: <pub-id pub-id-type="pmid">32148597</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>C. W.</given-names></name> <name><surname>Deng</surname> <given-names>X. Y.</given-names></name> <name><surname>Cheng</surname> <given-names>J. L.</given-names></name> <name><surname>Xiao</surname> <given-names>D. X.</given-names></name> <name><surname>Zhang</surname> <given-names>C. Y.</given-names></name> <name><surname>Feng</surname> <given-names>J. X.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Altered anxiety and social behaviors in a mouse model of fragile X syndrome treated with hyperbaric oxygen therapy</article-title>. <source>J. Clin. Neurosci.</source> <volume>73</volume>, <fpage>245</fpage>&#x2013;<lpage>251</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jocn.2020.02.004</pub-id>, PMID: <pub-id pub-id-type="pmid">32067828</pub-id></citation></ref>
<ref id="ref48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malik-Soni</surname> <given-names>N.</given-names></name> <name><surname>Shaker</surname> <given-names>A.</given-names></name> <name><surname>Luck</surname> <given-names>H.</given-names></name> <name><surname>Mullin</surname> <given-names>A. E.</given-names></name> <name><surname>Wiley</surname> <given-names>R. E.</given-names></name> <name><surname>Lewis</surname> <given-names>M. E. S.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Tackling healthcare access barriers for individuals with autism from diagnosis to adulthood</article-title>. <source>Pediatric Res.</source> <volume>91</volume>, <fpage>1028</fpage>&#x2013;<lpage>1035</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41390-021-01465-y</pub-id>, PMID: <pub-id pub-id-type="pmid">33767375</pub-id></citation></ref>
<ref id="ref49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Margari</surname> <given-names>L.</given-names></name> <name><surname>De Giacomo</surname> <given-names>A.</given-names></name> <name><surname>Craig</surname> <given-names>F.</given-names></name> <name><surname>Palumbi</surname> <given-names>R.</given-names></name> <name><surname>Peschechera</surname> <given-names>A.</given-names></name> <name><surname>Margari</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Frontal lobe metabolic alterations in autism spectrum disorder: A1h-magnetic resonance spectroscopy study</article-title>. <source>Neuropsychiatr. Dis. Treat.</source> <volume>14</volume>, <fpage>1871</fpage>&#x2013;<lpage>1876</lpage>. doi: <pub-id pub-id-type="doi">10.2147/ndt.s165375</pub-id>, PMID: <pub-id pub-id-type="pmid">30050301</pub-id></citation></ref>
<ref id="ref50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Markram</surname> <given-names>K.</given-names></name> <name><surname>Rinaldi</surname> <given-names>T.</given-names></name> <name><surname>Mendola</surname> <given-names>D.</given-names><prefix>La</prefix></name> <name><surname>Sandi</surname> <given-names>C.</given-names></name> <name><surname>Markram</surname> <given-names>H.</given-names></name></person-group> (<year>2008</year>). <article-title>Abnormal fear conditioning and amygdala processing in an animal model of autism</article-title>. <source>Neuropsychopharmacology</source>, <volume>33</volume>, <fpage>901</fpage>&#x2013;<lpage>912</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.npp.1301453</pub-id>, PMID: <pub-id pub-id-type="pmid">17507914</pub-id></citation></ref>
<ref id="ref51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martucci</surname> <given-names>L.</given-names></name> <name><surname>Wong</surname> <given-names>A. H. C.</given-names></name> <name><surname>De Luca</surname> <given-names>V.</given-names></name> <name><surname>Likhodi</surname> <given-names>O.</given-names></name> <name><surname>Wong</surname> <given-names>G. W. H.</given-names></name> <name><surname>King</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>N-methyl-d-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: polymorphisms and mRNA levels</article-title>. <source>Schizophr. Res.</source> <volume>84</volume>, <fpage>214</fpage>&#x2013;<lpage>221</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.schres.2006.02.001</pub-id>, PMID: <pub-id pub-id-type="pmid">16549338</pub-id></citation></ref>
<ref id="ref52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McKinnell</surname> <given-names>Z. E.</given-names></name> <name><surname>Maze</surname> <given-names>T.</given-names></name> <name><surname>Ramos</surname> <given-names>A.</given-names></name> <name><surname>Challans</surname> <given-names>B.</given-names></name> <name><surname>Plakke</surname> <given-names>B.</given-names></name></person-group> (<year>2021</year>). <article-title>Valproic acid treated female long-Evans rats are impaired on attentional set-shifting</article-title>. <source>Behav. Brain Res.</source> <volume>397</volume>:<fpage>112966</fpage>. doi: <pub-id pub-id-type="doi">10.1016/J.BBR.2020.112966</pub-id>, PMID: <pub-id pub-id-type="pmid">33053383</pub-id></citation></ref>
<ref id="ref53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohapatra</surname> <given-names>A. N.</given-names></name> <name><surname>Wagner</surname> <given-names>S.</given-names></name></person-group> (<year>2023</year>). <article-title>The role of the prefrontal cortex in social interactions of animal models and the implications for autism spectrum disorder</article-title>. <source>Front. Psychiatry</source> <volume>14</volume>:<fpage>1205199</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2023.1205199</pub-id>, PMID: <pub-id pub-id-type="pmid">37409155</pub-id></citation></ref>
<ref id="ref54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moy</surname> <given-names>S. S.</given-names></name> <name><surname>Nadler</surname> <given-names>J. J.</given-names></name> <name><surname>Perez</surname> <given-names>A.</given-names></name> <name><surname>Barbaro</surname> <given-names>R. P.</given-names></name> <name><surname>Johns</surname> <given-names>J. M.</given-names></name> <name><surname>Magnuson</surname> <given-names>T. R.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice</article-title>. <source>Genes Brain Behav.</source> <volume>3</volume>, <fpage>287</fpage>&#x2013;<lpage>302</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1601-1848.2004.00076.x</pub-id>, PMID: <pub-id pub-id-type="pmid">15344922</pub-id></citation></ref>
<ref id="ref55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ness</surname> <given-names>V.</given-names></name> <name><surname>Arning</surname> <given-names>L.</given-names></name> <name><surname>Niesert</surname> <given-names>H. E.</given-names></name> <name><surname>Stuettgen</surname> <given-names>M. C.</given-names></name> <name><surname>Epplen</surname> <given-names>J. T.</given-names></name> <name><surname>Beste</surname> <given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Variations in the GRIN2B gene are associated with risky decision-making</article-title>. <source>Neuropharmacology</source> <volume>61</volume>, <fpage>950</fpage>&#x2013;<lpage>956</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuropharm.2011.06.023</pub-id>, PMID: <pub-id pub-id-type="pmid">21749895</pub-id></citation></ref>
<ref id="ref56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nisar</surname> <given-names>S.</given-names></name> <name><surname>Bhat</surname> <given-names>A. A.</given-names></name> <name><surname>Masoodi</surname> <given-names>T.</given-names></name> <name><surname>Hashem</surname> <given-names>S.</given-names></name> <name><surname>Akhtar</surname> <given-names>S.</given-names></name> <name><surname>Ali</surname> <given-names>T. A.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Genetics of glutamate and its receptors in autism spectrum disorder</article-title>. <source>Molecular Psychiatry</source> <volume>27</volume>, <fpage>2380</fpage>&#x2013;<lpage>2392</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41380-022-01506-w</pub-id>, PMID: <pub-id pub-id-type="pmid">35296811</pub-id></citation></ref>
<ref id="ref57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Onaolapo</surname> <given-names>O. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Elevated plus Maze and Y-Maze behavioral effects of subchronic, Oral low dose monosodium glutamate in Swiss albino mice</article-title>. <source>IOSR J. Pharm. Biol. Sci.</source> <volume>3</volume>, <fpage>21</fpage>&#x2013;<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.9790/3008-0342127</pub-id></citation></ref>
<ref id="ref58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pels&#x0151;czi</surname> <given-names>P.</given-names></name> <name><surname>Kelemen</surname> <given-names>K.</given-names></name> <name><surname>Cs&#x00F6;lle</surname> <given-names>C.</given-names></name> <name><surname>Nagy</surname> <given-names>G.</given-names></name> <name><surname>Lendvai</surname> <given-names>B.</given-names></name> <name><surname>Rom&#x00E1;n</surname> <given-names>V.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Disrupted social hierarchy in prenatally valproate-exposed autistic-like rats</article-title>. <source>Front. Behav. Neurosci.</source> <volume>13</volume>:<fpage>295</fpage>. doi: <pub-id pub-id-type="doi">10.3389/FNBEH.2019.00295</pub-id>, PMID: <pub-id pub-id-type="pmid">32009915</pub-id></citation></ref>
<ref id="ref59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>Y.</given-names></name> <name><surname>Feng</surname> <given-names>S. F.</given-names></name> <name><surname>Wang</surname> <given-names>Q.</given-names></name> <name><surname>Wang</surname> <given-names>H. N.</given-names></name> <name><surname>Hou</surname> <given-names>W. G.</given-names></name> <name><surname>Xiong</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Hyperbaric oxygen preconditioning ameliorates anxiety-like behavior and cognitive impairments via upregulation of thioredoxin reductases in stressed rats</article-title>. <source>Prog. Neuro-Psychopharmacol. Biol. Psychiatry</source> <volume>34</volume>, <fpage>1018</fpage>&#x2013;<lpage>1025</lpage>. doi: <pub-id pub-id-type="doi">10.1016/J.PNPBP.2010.05.016</pub-id>, PMID: <pub-id pub-id-type="pmid">20493230</pub-id></citation></ref>
<ref id="ref60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pergola</surname> <given-names>G.</given-names></name> <name><surname>di Carlo</surname> <given-names>P.</given-names></name> <name><surname>Andriola</surname> <given-names>I.</given-names></name> <name><surname>Gelao</surname> <given-names>B.</given-names></name> <name><surname>Torretta</surname> <given-names>S.</given-names></name> <name><surname>Attrotto</surname> <given-names>M. T.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Combined effect of genetic variants in the GluN2B coding gene (GRIN2B) on prefrontal function during working memory performance</article-title>. <source>Psychol. Med.</source> <volume>46</volume>, <fpage>1135</fpage>&#x2013;<lpage>1150</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S0033291715002639</pub-id>, PMID: <pub-id pub-id-type="pmid">26690829</pub-id></citation></ref>
<ref id="ref61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pinheiro</surname> <given-names>J. C.</given-names></name> <name><surname>Bates</surname> <given-names>D. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Mixed-effects models in S and S-PLUS</article-title>. <source>Sci Open</source>:<fpage>528</fpage>. doi: <pub-id pub-id-type="doi">10.1007/978-1-4419-0318-1</pub-id></citation></ref>
<ref id="ref62"><citation citation-type="web"><person-group person-group-type="author"><collab id="coll3">R Core Team</collab></person-group>. (<year>2022</year>). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. Available at: <ext-link xlink:href="https://www.R-project.org/" ext-link-type="uri">https://www.R-project.org/</ext-link></citation></ref>
<ref id="ref63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajizadeh</surname> <given-names>M. A.</given-names></name> <name><surname>Afarinesh</surname> <given-names>M. R.</given-names></name> <name><surname>Zarif</surname> <given-names>M.</given-names></name> <name><surname>Mirasadi</surname> <given-names>A.</given-names></name> <name><surname>Esmaeilpour</surname> <given-names>K.</given-names></name></person-group> (<year>2019</year>). <article-title>Does caffeine therapy improve cognitive impairments in valproic acid rat model of autism?</article-title> <source>Toxin Rev.</source> <volume>40</volume>, <fpage>654</fpage>&#x2013;<lpage>664</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15569543.2019.1680563</pub-id></citation></ref>
<ref id="ref64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rein</surname> <given-names>B.</given-names></name> <name><surname>Ma</surname> <given-names>K.</given-names></name> <name><surname>Yan</surname> <given-names>Z.</given-names></name></person-group> (<year>2020</year>). <article-title>A standardized social preference protocol for measuring social deficits in mouse models of autism</article-title>. <source>Nat. Protoc.</source> <volume>15</volume>, <fpage>3464</fpage>&#x2013;<lpage>3477</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41596-020-0382-9</pub-id>, PMID: <pub-id pub-id-type="pmid">32895524</pub-id></citation></ref>
<ref id="ref65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rinaldi</surname> <given-names>T.</given-names></name> <name><surname>Kulangara</surname> <given-names>K.</given-names></name> <name><surname>Antoniello</surname> <given-names>K.</given-names></name> <name><surname>Markram</surname> <given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid</article-title>. <source>PNAS</source> <volume>104</volume>, <fpage>13501</fpage>&#x2013;<lpage>13506</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0704391104</pub-id>, PMID: <pub-id pub-id-type="pmid">17675408</pub-id></citation></ref>
<ref id="ref66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname> <given-names>S.</given-names></name> <name><surname>Melnyk</surname> <given-names>S.</given-names></name> <name><surname>Pavliv</surname> <given-names>O.</given-names></name> <name><surname>Bai</surname> <given-names>S.</given-names></name> <name><surname>Nick</surname> <given-names>T. G.</given-names></name> <name><surname>Frye</surname> <given-names>R. E.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain</article-title>. <source>Transl. Psychiatry</source> <volume>2</volume>:<fpage>e134</fpage>. doi: <pub-id pub-id-type="doi">10.1038/tp.2012.61</pub-id>, PMID: <pub-id pub-id-type="pmid">22781167</pub-id></citation></ref>
<ref id="ref67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rossigno</surname> <given-names>D. A.</given-names></name> <name><surname>Rossignol</surname> <given-names>L. W.</given-names></name> <name><surname>Smith</surname> <given-names>S.</given-names></name> <name><surname>Schneider</surname> <given-names>C.</given-names></name> <name><surname>Logerquist</surname> <given-names>S.</given-names></name> <name><surname>Usman</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial</article-title>. <source>BMC Pediatr.</source> <volume>9</volume>:<fpage>2431</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2431-9-21</pub-id>, PMID: <pub-id pub-id-type="pmid">19284641</pub-id></citation></ref>
<ref id="ref68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rossignol</surname> <given-names>D. A.</given-names></name> <name><surname>Bradstreet</surname> <given-names>J. J.</given-names></name> <name><surname>Van Dyke</surname> <given-names>K.</given-names></name> <name><surname>Schneider</surname> <given-names>C.</given-names></name> <name><surname>Freedenfeld</surname> <given-names>S. H.</given-names></name> <name><surname>O&#x2019;Hara</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Hyperbaric oxygen treatment in autism spectrum disorders</article-title>. <source>Med. Gas Res.</source> <volume>2</volume>:<fpage>16</fpage>. doi: <pub-id pub-id-type="doi">10.1186/2045-9912-2-16/</pub-id>, PMID: <pub-id pub-id-type="pmid">22703610</pub-id></citation></ref>
<ref id="ref69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rossignol</surname> <given-names>D. A.</given-names></name> <name><surname>Rossignol</surname> <given-names>L. W.</given-names></name> <name><surname>Jill</surname> <given-names>S. J.</given-names></name> <name><surname>Melnyk</surname> <given-names>S.</given-names></name> <name><surname>Mumper</surname> <given-names>E.</given-names></name></person-group> (<year>2007</year>). <article-title>The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study</article-title>. <source>BMC Pediatr.</source> <volume>7</volume>:<fpage>36</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2431-7-36</pub-id>, PMID: <pub-id pub-id-type="pmid">18005455</pub-id></citation></ref>
<ref id="ref70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rudebeck</surname> <given-names>P. H.</given-names></name> <name><surname>Bannerman</surname> <given-names>D. M.</given-names></name> <name><surname>Rushworth</surname> <given-names>M. F. S.</given-names></name></person-group> (<year>2008</year>). <article-title>The contribution of distinct subregions of the ventromedial frontal cortex to emotion, social behavior, and decision making</article-title>. <source>Cogn. Affect. Behav. Neurosci.</source> <volume>8</volume>, <fpage>485</fpage>&#x2013;<lpage>497</lpage>. doi: <pub-id pub-id-type="doi">10.3758/CABN.8.4.485/METRICS</pub-id>, PMID: <pub-id pub-id-type="pmid">19033243</pub-id></citation></ref>
<ref id="ref71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saft</surname> <given-names>P.</given-names></name> <name><surname>Ga</surname> <given-names>C.</given-names></name> <name><surname>Brug</surname> <given-names>B.</given-names></name> <name><surname>Manzo</surname> <given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Characterization of four types of tail abnormalities in rats treated prenatally with valproic acid</article-title>. <source>ENeurobiologia</source> <volume>5</volume></citation></ref>
<ref id="ref72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sampanthavivat</surname> <given-names>M.</given-names></name> <name><surname>Singkhwa</surname> <given-names>W.</given-names></name> <name><surname>Chaiyakul</surname> <given-names>T.</given-names></name> <name><surname>Karoonyawanich</surname> <given-names>S.</given-names></name> <name><surname>Ajpru</surname> <given-names>H.</given-names></name></person-group> (<year>2012</year>). <article-title>Hyperbaric oxygen in the treatment of childhood autism: a randomised controlled trial</article-title>. <source>Diving Hyperbaric Med.</source> <volume>42</volume>, <fpage>128</fpage>&#x2013;<lpage>133</lpage>.</citation></ref>
<ref id="ref73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sceniak</surname> <given-names>M. P.</given-names></name> <name><surname>Fedder</surname> <given-names>K. N.</given-names></name> <name><surname>Wang</surname> <given-names>Q.</given-names></name> <name><surname>Droubi</surname> <given-names>S.</given-names></name> <name><surname>Babcock</surname> <given-names>K.</given-names></name> <name><surname>Patwardhan</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>An autism-associated mutation in GluN2B prevents NMDA receptor trafficking and interferes with dendrite growth</article-title>. <source>J. Cell Sci.</source> <volume>132</volume>:<fpage>jcs232892</fpage>. doi: <pub-id pub-id-type="doi">10.1242/jcs.232892</pub-id></citation></ref>
<ref id="ref74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schimmel</surname> <given-names>S.</given-names></name> <name><surname>El Sayed</surname> <given-names>B.</given-names></name> <name><surname>Lockard</surname> <given-names>G.</given-names></name> <name><surname>Gordon</surname> <given-names>J.</given-names></name> <name><surname>Young</surname> <given-names>I.</given-names></name> <name><surname>D&#x2019;Egidio</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Identifying the target traumatic brain injury population for hyperbaric oxygen therapy</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume>:<fpage>14612</fpage>. doi: <pub-id pub-id-type="doi">10.3390/IJMS241914612</pub-id></citation></ref>
<ref id="ref75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmittgen</surname> <given-names>T. D.</given-names></name> <name><surname>Livak</surname> <given-names>K. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Analyzing real-time PCR data by the comparative CT method</article-title>. <source>Nat. Protoc.</source> <volume>3</volume>, <fpage>1101</fpage>&#x2013;<lpage>1108</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nprot.2008.73</pub-id></citation></ref>
<ref id="ref76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname> <given-names>T.</given-names></name> <name><surname>Przew&#x0142;ocki</surname> <given-names>R.</given-names></name></person-group> (<year>2004</year>). <article-title>Behavioral alterations in rats prenatally exposed to Valproic acid: animal model of autism</article-title>. <source>Neuropsychopharmacology</source> <volume>30</volume>, <fpage>80</fpage>&#x2013;<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.npp.1300518</pub-id></citation></ref>
<ref id="ref77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname> <given-names>T.</given-names></name> <name><surname>Turczak</surname> <given-names>J.</given-names></name> <name><surname>Przew&#x0142;ocki</surname> <given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>Environmental enrichment reverses behavioral alterations in rats prenatally exposed to Valproic acid: issues for a therapeutic approach in autism</article-title>. <source>Neuropsychopharmacology</source> <volume>31</volume>, <fpage>36</fpage>&#x2013;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.npp.1300767</pub-id>, PMID: <pub-id pub-id-type="pmid">15920505</pub-id></citation></ref>
<ref id="ref78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simsek</surname> <given-names>K.</given-names></name> <name><surname>Ozler</surname> <given-names>M.</given-names></name> <name><surname>Yildirim</surname> <given-names>A. O.</given-names></name> <name><surname>Sadir</surname> <given-names>S.</given-names></name> <name><surname>Demirbas</surname> <given-names>S.</given-names></name> <name><surname>Oztosun</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Evaluation of the oxidative effect of long-term repetitive hyperbaric oxygen exposures on different brain regions of rats</article-title>. <source>Sci. World J.</source> <volume>2012</volume>, <fpage>1</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1100/2012/849183</pub-id>, PMID: <pub-id pub-id-type="pmid">22454610</pub-id></citation></ref>
<ref id="ref79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname> <given-names>C. M.</given-names></name> <name><surname>Alekseyenko</surname> <given-names>O.</given-names></name> <name><surname>Serysheva</surname> <given-names>E.</given-names></name> <name><surname>Yuva-Paylor</surname> <given-names>L. A.</given-names></name> <name><surname>Paylor</surname> <given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome</article-title>. <source>Genes Brain Behav.</source> <volume>4</volume>, <fpage>420</fpage>&#x2013;<lpage>430</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1601-183X.2005.00123.x</pub-id>, PMID: <pub-id pub-id-type="pmid">16176388</pub-id></citation></ref>
<ref id="ref80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tal</surname> <given-names>S.</given-names></name> <name><surname>Hadanny</surname> <given-names>A.</given-names></name> <name><surname>Sasson</surname> <given-names>E.</given-names></name> <name><surname>Suzin</surname> <given-names>G.</given-names></name> <name><surname>Efrati</surname> <given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Hyperbaric oxygen therapy can induce angiogenesis and regeneration of nerve fibers in traumatic brain injury patients</article-title>. <source>Front. Hum. Neurosci.</source> <volume>11</volume>:<fpage>508</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnhum.2017.00508</pub-id>, PMID: <pub-id pub-id-type="pmid">29097988</pub-id></citation></ref>
<ref id="ref81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turpaev</surname> <given-names>K. T.</given-names></name></person-group> (<year>2002</year>). <article-title>Reactive oxygen species and regulation of gene expression</article-title>. <source>Biochem. Mosc.</source> <volume>67</volume>, <fpage>281</fpage>&#x2013;<lpage>292</lpage>. doi: <pub-id pub-id-type="doi">10.1023/A:1014819832003</pub-id></citation></ref>
<ref id="ref82"><citation citation-type="book"><person-group person-group-type="author"><collab id="coll4">Undersea and Hyperbaric Medical Society (UHMS)</collab></person-group>. (<year>2019</year>). <source>Undersea and hyperbaric medical society hyperbaric oxygen therapy indications</source>. <edition>14th</edition> Edn). <publisher-loc>New York</publisher-loc>: <publisher-name>Best Publishing Company</publisher-name>.</citation></ref>
<ref id="ref83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Usui</surname> <given-names>N.</given-names></name> <name><surname>Kobayashi</surname> <given-names>H.</given-names></name> <name><surname>Shimada</surname> <given-names>S.</given-names></name></person-group> (<year>2023</year>). <article-title>Neuroinflammation and oxidative stress in the pathogenesis of autism Spectrum disorder</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume>:<fpage>5487</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms24065487</pub-id>, PMID: <pub-id pub-id-type="pmid">36982559</pub-id></citation></ref>
<ref id="ref84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vorhees</surname> <given-names>C. V.</given-names></name> <name><surname>Williams</surname> <given-names>M. T.</given-names></name></person-group> (<year>2006</year>). <article-title>Morris water maze: procedures for assessing spatial and related forms of learning and memory</article-title>. <source>Nat. Protoc.</source> <volume>1</volume>, <fpage>848</fpage>&#x2013;<lpage>858</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nprot.2006.116</pub-id>, PMID: <pub-id pub-id-type="pmid">17406317</pub-id></citation></ref>
<ref id="ref85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>L. L.</given-names></name> <name><surname>Cui</surname> <given-names>J. F.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Shum</surname> <given-names>D. H. K.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>A Meta-analysis of working memory impairments in autism Spectrum disorders</article-title>. <source>Neuropsychol. Rev.</source> <volume>27</volume>, <fpage>46</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11065-016-9336-y</pub-id>, PMID: <pub-id pub-id-type="pmid">28102493</pub-id></citation></ref>
<ref id="ref86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>W&#x00F6;hr</surname> <given-names>M.</given-names></name> <name><surname>Orduz</surname> <given-names>D.</given-names></name> <name><surname>Gregory</surname> <given-names>P.</given-names></name> <name><surname>Moreno</surname> <given-names>H.</given-names></name> <name><surname>Khan</surname> <given-names>U.</given-names></name> <name><surname>V&#x00F6;rckel</surname> <given-names>K. J.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities. Translational</article-title>. <source>Psychiatry</source> <volume>5</volume>:<fpage>19</fpage>. doi: <pub-id pub-id-type="doi">10.1038/TP.2015.19</pub-id>, PMID: <pub-id pub-id-type="pmid">25756808</pub-id></citation></ref>
<ref id="ref87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>C.</given-names></name> <name><surname>Yang</surname> <given-names>Q.</given-names></name> <name><surname>Xiang</surname> <given-names>Y.</given-names></name> <name><surname>Zeng</surname> <given-names>X. R.</given-names></name> <name><surname>Xiao</surname> <given-names>J.</given-names></name> <name><surname>Le</surname> <given-names>W. D.</given-names></name></person-group> (<year>2023</year>). <article-title>The neuroprotective effects of oxygen therapy in Alzheimer&#x2019;s disease: a narrative review</article-title>. <source>Neural Regen. Res.</source> <volume>18</volume>, <fpage>57</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.4103/1673-5374.343897</pub-id>, PMID: <pub-id pub-id-type="pmid">35799509</pub-id></citation></ref>
<ref id="ref88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname> <given-names>H. J.</given-names></name> <name><surname>Cho</surname> <given-names>I. H.</given-names></name> <name><surname>Park</surname> <given-names>M.</given-names></name> <name><surname>Yang</surname> <given-names>S. Y.</given-names></name> <name><surname>Kim</surname> <given-names>S. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Family based association of GRIN2A and GRIN2B with Korean autism spectrum disorders</article-title>. <source>Neurosci. Lett.</source> <volume>512</volume>, <fpage>89</fpage>&#x2013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neulet.2012.01.061</pub-id>, PMID: <pub-id pub-id-type="pmid">22326929</pub-id></citation></ref>
<ref id="ref89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>X. W.</given-names></name> <name><surname>Zhang</surname> <given-names>L. L.</given-names></name> <name><surname>Zhu</surname> <given-names>Z. M.</given-names></name> <name><surname>Wang</surname> <given-names>L. Y.</given-names></name> <name><surname>Ding</surname> <given-names>Z. X.</given-names></name> <name><surname>Fang</surname> <given-names>X. M.</given-names></name></person-group> (<year>2022</year>). <article-title>Altered intrinsic brain activity and connectivity in unaffected parents of individuals with autism spectrum disorder: a resting-state fMRI study</article-title>. <source>Front. Hum. Neurosci.</source> <volume>16</volume>:<fpage>997150</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnhum.2022.997150</pub-id>, PMID: <pub-id pub-id-type="pmid">36248683</pub-id></citation></ref>
</ref-list>
</back>
</article>
